| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cadherin binding | FLNB TRIM25 KRT18 CDHR3 CHMP5 KTN1 ITGA6 TLN1 MACF1 CTNND1 CTNND2 RAB1A GCN1 CDH5 | 2.84e-08 | 339 | 125 | 14 | GO:0045296 |
| GeneOntologyMolecularFunction | DNA secondary structure binding | 2.00e-07 | 41 | 125 | 6 | GO:0000217 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | FLNB TRIM25 KRT18 CDHR3 CHMP5 KTN1 ITGA6 TLN1 CD47 MACF1 TLN2 CTNND1 CTNND2 RAB1A GCN1 UTRN CDH5 | 2.04e-07 | 599 | 125 | 17 | GO:0050839 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.61e-06 | 130 | 125 | 8 | GO:0005200 | |
| GeneOntologyMolecularFunction | four-way junction DNA binding | 5.27e-06 | 19 | 125 | 4 | GO:0000400 | |
| GeneOntologyMolecularFunction | actin binding | FLNB FLNC ANXA8L1 ANXA8 ITPRID2 EPB41L3 TLN1 ENAH MACF1 TLN2 UTRN EPB41 EPB41L2 | 9.86e-06 | 479 | 125 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | FLNB FLNC KTN1 ANXA8L1 ACTB NUMA1 ANXA8 ITPRID2 EPB41L3 BMP10 TLN1 ENAH MACF1 TLN2 USH2A UTRN EPB41 EPB41L2 KIF25 NLRP5 | 1.58e-05 | 1099 | 125 | 20 | GO:0008092 |
| GeneOntologyMolecularFunction | unmethylated CpG binding | 2.78e-05 | 10 | 125 | 3 | GO:0045322 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL17A1 KRT18 ACTB NUMA1 ACTG1 LMNB2 SRBD1 EPB41L3 KRT24 LMNB1 TLN1 MACF1 TLN2 CTNND2 KRT36 EPB41 EPB41L2 | 4.08e-05 | 891 | 125 | 17 | GO:0005198 |
| GeneOntologyMolecularFunction | actin filament binding | 9.27e-05 | 227 | 125 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | RAD51B DDX19B ACTB RSF1 CHD2 FANCM ABCB1 ATAD2B ACIN1 MACF1 KIF25 | 1.04e-04 | 441 | 125 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | RAD51B DDX19B ACTB RSF1 CHD2 FANCM ABCB1 ATAD2B UBA6 ACIN1 MACF1 KIF25 | 4.79e-04 | 614 | 125 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 8.54e-04 | 316 | 125 | 8 | GO:0035091 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 8.59e-04 | 30 | 125 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 9.47e-04 | 31 | 125 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 1.04e-03 | 32 | 125 | 3 | GO:0099186 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.06e-03 | 8 | 125 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone binding | 1.41e-03 | 265 | 125 | 7 | GO:0042393 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.69e-03 | 10 | 125 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity | 2.06e-03 | 11 | 125 | 2 | GO:0052629 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 2.06e-03 | 11 | 125 | 2 | GO:0098973 | |
| GeneOntologyMolecularFunction | minor groove of adenine-thymine-rich DNA binding | 2.06e-03 | 11 | 125 | 2 | GO:0003680 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 2.30e-03 | 42 | 125 | 3 | GO:0098918 | |
| GeneOntologyMolecularFunction | profilin binding | 2.90e-03 | 13 | 125 | 2 | GO:0005522 | |
| GeneOntologyMolecularFunction | vinculin binding | 2.90e-03 | 13 | 125 | 2 | GO:0017166 | |
| GeneOntologyBiologicalProcess | heterochromatin formation | 5.48e-07 | 163 | 122 | 9 | GO:0031507 | |
| GeneOntologyBiologicalProcess | actin filament-based process | FLNB FLNC SCN11A ABR ACTB ACTG1 EPB41L3 BCR SH3D21 RYR2 FAT1 BMP10 TLN1 ENAH CD47 TLN2 EPB41 EPB41L2 NLRP5 | 1.69e-06 | 912 | 122 | 19 | GO:0030029 |
| GeneOntologyBiologicalProcess | negative regulation of gene expression, epigenetic | 3.39e-06 | 203 | 122 | 9 | GO:0045814 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to cell cortex | 3.99e-06 | 6 | 122 | 3 | GO:1904778 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | KMT2B KDM5A LMNB2 MECP2 MEN1 RIF1 LMNB1 BAZ2A ATAD2B KMT2A CDK2 | 4.31e-06 | 330 | 122 | 11 | GO:0040029 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | FLNB FLNC ABR ACTB ACTG1 EPB41L3 BCR SH3D21 FAT1 BMP10 TLN1 ENAH CD47 TLN2 EPB41 EPB41L2 NLRP5 | 5.11e-06 | 803 | 122 | 17 | GO:0030036 |
| GeneOntologyBiologicalProcess | cell-cell junction assembly | 6.87e-06 | 167 | 122 | 8 | GO:0007043 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to cell cortex | 1.65e-05 | 9 | 122 | 3 | GO:1904776 | |
| GeneOntologyBiologicalProcess | cell junction organization | COL17A1 CDHR3 ACTB ITGA6 ACTG1 MPDZ EPB41L3 BCR MECP2 TLN1 CD47 MTMR2 PALM LRP5 MACF1 TLN2 CTNND2 CDH5 | 1.68e-05 | 974 | 122 | 18 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell junction assembly | COL17A1 CDHR3 ACTB ITGA6 ACTG1 MPDZ EPB41L3 BCR MECP2 TLN1 MACF1 TLN2 CDH5 | 3.29e-05 | 569 | 122 | 13 | GO:0034329 |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | TRAF6 GGA2 KRT18 ACTB NUMA1 EPB41L3 PALM MACF1 EPB41 GOLGA4 EPB41L2 | 4.23e-05 | 422 | 122 | 11 | GO:1990778 |
| GeneOntologyBiologicalProcess | protein localization to cell cortex | 4.27e-05 | 12 | 122 | 3 | GO:0072697 | |
| GeneOntologyBiologicalProcess | cell-substrate junction assembly | 4.43e-05 | 108 | 122 | 6 | GO:0007044 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | RAG1 TRAF6 KRT18 CDHR3 ACTB ITGA6 ACTG1 UFL1 STK10 MALT1 FAT1 TLN1 CD47 LRP5 TLN2 CTNND1 CTNND2 CDH5 | 6.27e-05 | 1077 | 122 | 18 | GO:0098609 |
| GeneOntologyBiologicalProcess | cell-substrate junction organization | 6.30e-05 | 115 | 122 | 6 | GO:0150115 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | SCN11A CCDC186 CHMP5 NUMA1 LMNB2 MECP2 DSN1 LMNB1 PIBF1 RAB1A KIF25 NLRP5 | 9.70e-05 | 546 | 122 | 12 | GO:0051656 |
| GeneOntologyBiologicalProcess | negative regulation of phospholipase A2 activity | 1.04e-04 | 3 | 122 | 2 | GO:1900138 | |
| GeneOntologyBiologicalProcess | negative regulation of neutrophil degranulation | 1.04e-04 | 3 | 122 | 2 | GO:0043314 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 1.09e-04 | 246 | 122 | 8 | GO:0045216 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | KMT2B KDM5A ACTB RSF1 CHD2 LMNB2 MECP2 MEN1 RIF1 LMNB1 BAZ2A ATAD2B KMT2A CDK2 | 1.25e-04 | 741 | 122 | 14 | GO:0006338 |
| GeneOntologyBiologicalProcess | epithelium development | RAD51B FLNB TRAF6 ACTB NUMA1 ACTG1 BCR RYR2 ABCB1 MEN1 FAT1 KRT24 ENAH LRP5 IFT122 CTNND1 RAB1A USH2A POU2F3 CDH5 KRT36 | 1.36e-04 | 1469 | 122 | 21 | GO:0060429 |
| GeneOntologyBiologicalProcess | cortical actin cytoskeleton organization | 1.44e-04 | 45 | 122 | 4 | GO:0030866 | |
| GeneOntologyBiologicalProcess | Golgi to plasma membrane protein transport | 1.44e-04 | 45 | 122 | 4 | GO:0043001 | |
| GeneOntologyBiologicalProcess | response to L-glutamate | 1.54e-04 | 18 | 122 | 3 | GO:1902065 | |
| GeneOntologyBiologicalProcess | intracellular transport | DDX19B GGA2 MLX RBM33 CCDC186 CHMP5 ANXA8L1 NUMA1 MPDZ ANXA8 LMNB2 BCR RUFY1 MECP2 MALT1 LMNB1 MTMR2 IFT122 DENND5A SPAG17 RAB1A | 1.76e-04 | 1496 | 122 | 21 | GO:0046907 |
| GeneOntologyBiologicalProcess | regulation of transepithelial transport | 2.07e-04 | 4 | 122 | 2 | GO:0150111 | |
| GeneOntologyBiologicalProcess | chromatin organization | RAG1 KMT2B KDM5A ACTB RSF1 CHD2 LMNB2 MECP2 MEN1 RIF1 LMNB1 BAZ2A ATAD2B KMT2A CDK2 | 2.65e-04 | 896 | 122 | 15 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | RAG1 KMT2B KDM5A ACTB RSF1 CHD2 LMNB2 MECP2 MEN1 RIF1 BRF1 LMNB1 BAZ2A ATAD2B KMT2A CDK2 | 2.69e-04 | 999 | 122 | 16 | GO:0071824 |
| GeneOntologyBiologicalProcess | G2/M transition of mitotic cell cycle | 2.90e-04 | 152 | 122 | 6 | GO:0000086 | |
| GeneOntologyBiologicalProcess | facultative heterochromatin formation | 3.15e-04 | 55 | 122 | 4 | GO:0140718 | |
| GeneOntologyBiologicalProcess | response to electrical stimulus | 3.37e-04 | 56 | 122 | 4 | GO:0051602 | |
| GeneOntologyBiologicalProcess | nuclear pore localization | 3.43e-04 | 5 | 122 | 2 | GO:0051664 | |
| GeneOntologyBiologicalProcess | negative regulation of phospholipase activity | 3.43e-04 | 5 | 122 | 2 | GO:0010519 | |
| GeneOntologyBiologicalProcess | cortical cytoskeleton organization | 3.61e-04 | 57 | 122 | 4 | GO:0030865 | |
| GeneOntologyBiologicalProcess | response to nitric oxide | 3.73e-04 | 24 | 122 | 3 | GO:0071731 | |
| GeneOntologyBiologicalProcess | protein localization to cell-cell junction | 3.73e-04 | 24 | 122 | 3 | GO:0150105 | |
| GeneOntologyBiologicalProcess | protein localization to bicellular tight junction | 5.12e-04 | 6 | 122 | 2 | GO:1902396 | |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol dephosphorylation | 5.12e-04 | 6 | 122 | 2 | GO:0060304 | |
| GeneOntologyBiologicalProcess | cell cycle G2/M phase transition | 5.44e-04 | 171 | 122 | 6 | GO:0044839 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 5.56e-04 | 239 | 122 | 7 | GO:0031032 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | FLNB SCN11A CDHR3 ACTB ACTG1 PALMD EPB41L3 MECP2 FAT1 ENAH PALM MACF1 CTNND2 CDH5 EPB41 GOLGA4 EPB41L2 | 6.63e-04 | 1194 | 122 | 17 | GO:0000902 |
| GeneOntologyBiologicalProcess | negative regulation of blood vessel remodeling | 7.15e-04 | 7 | 122 | 2 | GO:0060313 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 7.50e-04 | 410 | 122 | 9 | GO:0031589 | |
| GeneOntologyCellularComponent | cell cortex | FLNB TRAF6 FRMPD1 ACTB NUMA1 MELK LANCL2 AKAP12 MACF1 CTNND1 EPB41 EPB41L2 NLRP5 | 2.70e-07 | 371 | 122 | 13 | GO:0005938 |
| GeneOntologyCellularComponent | anchoring junction | FLNB FLNC COL17A1 KRT18 CDHR3 ACTB ITGA6 ACTG1 MPDZ EPB41L3 AKAP12 ABCB1 FAT1 TLN1 ENAH TLN2 CTNND1 CTNND2 CDH5 EPB41L2 | 9.15e-07 | 976 | 122 | 20 | GO:0070161 |
| GeneOntologyCellularComponent | cell-cell junction | COL17A1 KRT18 CDHR3 ACTB ITGA6 ACTG1 MPDZ EPB41L3 ABCB1 FAT1 TLN1 TLN2 CTNND1 CTNND2 CDH5 | 1.87e-06 | 591 | 122 | 15 | GO:0005911 |
| GeneOntologyCellularComponent | cell-substrate junction | FLNB FLNC COL17A1 ACTB ITGA6 ACTG1 AKAP12 FAT1 TLN1 ENAH TLN2 EPB41L2 | 1.12e-05 | 443 | 122 | 12 | GO:0030055 |
| GeneOntologyCellularComponent | adherens junction | 3.51e-05 | 212 | 122 | 8 | GO:0005912 | |
| GeneOntologyCellularComponent | focal adhesion | FLNB FLNC ACTB ITGA6 ACTG1 AKAP12 FAT1 TLN1 ENAH TLN2 EPB41L2 | 4.55e-05 | 431 | 122 | 11 | GO:0005925 |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 3.00e-04 | 155 | 122 | 6 | GO:0098685 | |
| GeneOntologyCellularComponent | lamin filament | 4.99e-04 | 6 | 122 | 2 | GO:0005638 | |
| GeneOntologyCellularComponent | nuclear periphery | 5.07e-04 | 171 | 122 | 6 | GO:0034399 | |
| GeneOntologyCellularComponent | apicolateral plasma membrane | 5.71e-04 | 28 | 122 | 3 | GO:0016327 | |
| GeneOntologyCellularComponent | dense body | 6.96e-04 | 7 | 122 | 2 | GO:0097433 | |
| GeneOntologyCellularComponent | cell leading edge | 7.07e-04 | 500 | 122 | 10 | GO:0031252 | |
| GeneOntologyCellularComponent | filopodium | 7.78e-04 | 123 | 122 | 5 | GO:0030175 | |
| GeneOntologyCellularComponent | catenin complex | 8.50e-04 | 32 | 122 | 3 | GO:0016342 | |
| GeneOntologyCellularComponent | MLL1/2 complex | 9.31e-04 | 33 | 122 | 3 | GO:0044665 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 9.64e-04 | 129 | 122 | 5 | GO:0030863 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 1.26e-03 | 137 | 122 | 5 | GO:0019897 | |
| GeneOntologyCellularComponent | postsynaptic density | 1.33e-03 | 451 | 122 | 9 | GO:0014069 | |
| GeneOntologyCellularComponent | supramolecular fiber | FLNB FLNC KRT18 CHMP5 ACTB NUMA1 ACTG1 LMNB2 RYR2 KRT24 LMNB1 BMP10 MACF1 SPAG17 KRT36 KIF25 | 1.38e-03 | 1179 | 122 | 16 | GO:0099512 |
| GeneOntologyCellularComponent | nuclear matrix | 1.39e-03 | 140 | 122 | 5 | GO:0016363 | |
| GeneOntologyCellularComponent | supramolecular polymer | FLNB FLNC KRT18 CHMP5 ACTB NUMA1 ACTG1 LMNB2 RYR2 KRT24 LMNB1 BMP10 MACF1 SPAG17 KRT36 KIF25 | 1.48e-03 | 1187 | 122 | 16 | GO:0099081 |
| GeneOntologyCellularComponent | nuclear envelope | 1.66e-03 | 560 | 122 | 10 | GO:0005635 | |
| GeneOntologyCellularComponent | hemidesmosome | 1.80e-03 | 11 | 122 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | asymmetric synapse | 1.95e-03 | 477 | 122 | 9 | GO:0032279 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 2.04e-03 | 576 | 122 | 10 | GO:0015629 | |
| GeneOntologyCellularComponent | intermediate filament | 2.18e-03 | 227 | 122 | 6 | GO:0005882 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 2.25e-03 | 94 | 122 | 4 | GO:0000123 | |
| GeneOntologyCellularComponent | cell cortex region | 2.30e-03 | 45 | 122 | 3 | GO:0099738 | |
| GeneOntologyCellularComponent | apical junction complex | 2.36e-03 | 158 | 122 | 5 | GO:0043296 | |
| GeneOntologyCellularComponent | postsynapse | ABR ACTB ACTG1 MPDZ PALMD EPB41L3 BCR MECP2 MTMR2 PALM MACF1 CTNND1 CTNND2 UTRN | 2.47e-03 | 1018 | 122 | 14 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic specialization | 2.78e-03 | 503 | 122 | 9 | GO:0099572 | |
| GeneOntologyCellularComponent | ISWI-type complex | 2.94e-03 | 14 | 122 | 2 | GO:0031010 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 2.94e-03 | 49 | 122 | 3 | GO:0099092 | |
| GeneOntologyCellularComponent | dendritic spine | 2.99e-03 | 242 | 122 | 6 | GO:0043197 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 3.24e-03 | 104 | 122 | 4 | GO:0031248 | |
| GeneOntologyCellularComponent | neuron spine | 3.31e-03 | 247 | 122 | 6 | GO:0044309 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 3.60e-03 | 523 | 122 | 9 | GO:0098984 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 3.83e-03 | 109 | 122 | 4 | GO:1902493 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 4.29e-03 | 56 | 122 | 3 | GO:0099091 | |
| GeneOntologyCellularComponent | nuclear lamina | 4.34e-03 | 17 | 122 | 2 | GO:0005652 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 4.49e-03 | 263 | 122 | 6 | GO:0045111 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | ELOA2 KMT2B CHMP5 KIAA0586 ACTB NUMA1 UFL1 ERVW-1 RYR2 MEN1 BMP10 AIFM1 TLN1 KMT2A IFT122 RAB1A CDH5 | 2.47e-05 | 700 | 108 | 17 | MP:0011098 |
| MousePheno | embryonic lethality during organogenesis | FLNB ELOA2 KMT2B CHMP5 KIAA0586 ACTB NUMA1 UFL1 ERVW-1 RYR2 MEN1 RIF1 BMP10 AIFM1 TLN1 KMT2A IFT122 RAB1A CDH5 | 3.74e-05 | 876 | 108 | 19 | MP:0006207 |
| MousePheno | abnormal gastrulation movements | 5.17e-05 | 10 | 108 | 3 | MP:0002174 | |
| MousePheno | abnormal embryonic growth/weight/body size | SUPT20HL1 ELOA2 KMT2B ACAT2 CCDC186 CHMP5 ACTB RSF1 ACTG1 UFL1 SUPT20HL2 ERVW-1 RYR2 MEN1 HARS2 RIF1 LMNB1 BMP10 AIFM1 TLN1 PIBF1 GCN1 CDH5 | 1.16e-04 | 1295 | 108 | 23 | MP:0002088 |
| MousePheno | tachypnea | 1.21e-04 | 13 | 108 | 3 | MP:0005426 | |
| MousePheno | abnormal cardiovascular development | SUPT20HL1 FLNB FLNC TRAF6 EOGT KMT2B CHMP5 KIAA0586 SUPT20HL2 ERVW-1 RYR2 BMP10 CD47 LRP5 IFT122 PIBF1 CDH5 | 1.34e-04 | 802 | 108 | 17 | MP:0002925 |
| MousePheno | abnormal prenatal growth/weight/body size | SUPT20HL1 FLNC ELOA2 KMT2B ACAT2 CCDC186 CHMP5 ACTB RSF1 ACTG1 UFL1 SUPT20HL2 CHD2 ERVW-1 RYR2 MEN1 HARS2 RIF1 LMNB1 BMP10 AIFM1 TLN1 PIBF1 GCN1 CDH5 | 1.42e-04 | 1493 | 108 | 25 | MP:0004196 |
| MousePheno | decreased bone resorption | 1.64e-04 | 36 | 108 | 4 | MP:0004993 | |
| Domain | FERM_N | 6.91e-08 | 33 | 123 | 6 | IPR018979 | |
| Domain | FERM_N | 6.91e-08 | 33 | 123 | 6 | PF09379 | |
| Domain | FERM_CS | 4.39e-07 | 24 | 123 | 5 | IPR019747 | |
| Domain | FERM_M | 5.45e-07 | 46 | 123 | 6 | PF00373 | |
| Domain | - | 8.00e-07 | 49 | 123 | 6 | 1.20.80.10 | |
| Domain | FERM_central | 8.00e-07 | 49 | 123 | 6 | IPR019748 | |
| Domain | FERM_domain | 8.00e-07 | 49 | 123 | 6 | IPR000299 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 9.05e-07 | 50 | 123 | 6 | IPR014352 | |
| Domain | FERM_1 | 9.05e-07 | 50 | 123 | 6 | PS00660 | |
| Domain | FERM_2 | 9.05e-07 | 50 | 123 | 6 | PS00661 | |
| Domain | FERM_3 | 9.05e-07 | 50 | 123 | 6 | PS50057 | |
| Domain | Band_41_domain | 9.05e-07 | 50 | 123 | 6 | IPR019749 | |
| Domain | B41 | 9.05e-07 | 50 | 123 | 6 | SM00295 | |
| Domain | 4_1_CTD | 1.11e-06 | 4 | 123 | 3 | PF05902 | |
| Domain | SAB | 1.11e-06 | 4 | 123 | 3 | PF04382 | |
| Domain | Band_4.1_C | 1.11e-06 | 4 | 123 | 3 | IPR008379 | |
| Domain | SAB_dom | 1.11e-06 | 4 | 123 | 3 | IPR007477 | |
| Domain | ACTININ_2 | 1.44e-05 | 23 | 123 | 4 | PS00020 | |
| Domain | ACTININ_1 | 1.44e-05 | 23 | 123 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.44e-05 | 23 | 123 | 4 | IPR001589 | |
| Domain | AT_hook | 2.80e-05 | 27 | 123 | 4 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 2.80e-05 | 27 | 123 | 4 | IPR017956 | |
| Domain | Paralemmin | 4.30e-05 | 2 | 123 | 2 | IPR004965 | |
| Domain | - | 4.30e-05 | 2 | 123 | 2 | 1.20.1420.10 | |
| Domain | AnnexinVIII | 4.30e-05 | 2 | 123 | 2 | IPR009115 | |
| Domain | VBS | 4.30e-05 | 2 | 123 | 2 | PF08913 | |
| Domain | MeTrfase_trithorax | 4.30e-05 | 2 | 123 | 2 | IPR016569 | |
| Domain | Lamin_B | 4.30e-05 | 2 | 123 | 2 | IPR027696 | |
| Domain | Vinculin-bd_dom | 4.30e-05 | 2 | 123 | 2 | IPR015009 | |
| Domain | Talin_cent | 4.30e-05 | 2 | 123 | 2 | IPR015224 | |
| Domain | Paralemmin | 4.30e-05 | 2 | 123 | 2 | PF03285 | |
| Domain | Talin_middle | 4.30e-05 | 2 | 123 | 2 | PF09141 | |
| Domain | Intermediate_filament_CS | 5.91e-05 | 63 | 123 | 5 | IPR018039 | |
| Domain | FA | 7.60e-05 | 13 | 123 | 3 | PF08736 | |
| Domain | FERM-adjacent | 7.60e-05 | 13 | 123 | 3 | IPR014847 | |
| Domain | FA | 7.60e-05 | 13 | 123 | 3 | SM01195 | |
| Domain | Filament | 1.05e-04 | 71 | 123 | 5 | SM01391 | |
| Domain | IF | 1.12e-04 | 72 | 123 | 5 | PS00226 | |
| Domain | PH_dom-like | ABR FRMPD1 MTMR1 EPB41L3 BCR TLN1 ENAH MTMR2 TLN2 EPB41 EPB41L2 | 1.19e-04 | 426 | 123 | 11 | IPR011993 |
| Domain | Filament | 1.20e-04 | 73 | 123 | 5 | PF00038 | |
| Domain | Talin-1 | 1.29e-04 | 3 | 123 | 2 | IPR015710 | |
| Domain | PHD | 1.36e-04 | 75 | 123 | 5 | PF00628 | |
| Domain | IF | 1.45e-04 | 76 | 123 | 5 | IPR001664 | |
| Domain | AT_hook | 1.47e-04 | 16 | 123 | 3 | PF02178 | |
| Domain | Znf_PHD-finger | 1.74e-04 | 79 | 123 | 5 | IPR019787 | |
| Domain | Ubiquitin-rel_dom | 2.18e-04 | 184 | 123 | 7 | IPR029071 | |
| Domain | ILWEQ_dom | 2.56e-04 | 4 | 123 | 2 | IPR002558 | |
| Domain | ILWEQ | 2.56e-04 | 4 | 123 | 2 | SM00307 | |
| Domain | FERM_f0 | 2.56e-04 | 4 | 123 | 2 | PF16511 | |
| Domain | ILWEQ | 2.56e-04 | 4 | 123 | 2 | PD011820 | |
| Domain | - | 2.56e-04 | 4 | 123 | 2 | 1.20.1410.10 | |
| Domain | I_LWEQ | 2.56e-04 | 4 | 123 | 2 | PF01608 | |
| Domain | I_LWEQ | 2.56e-04 | 4 | 123 | 2 | PS50945 | |
| Domain | FERM_f0 | 2.56e-04 | 4 | 123 | 2 | IPR032425 | |
| Domain | - | 2.65e-04 | 391 | 123 | 10 | 2.30.29.30 | |
| Domain | PHD | 3.05e-04 | 89 | 123 | 5 | SM00249 | |
| Domain | Znf_PHD | 3.38e-04 | 91 | 123 | 5 | IPR001965 | |
| Domain | Ez/rad/moesin-like | 3.40e-04 | 21 | 123 | 3 | IPR000798 | |
| Domain | ZF_PHD_2 | 4.12e-04 | 95 | 123 | 5 | PS50016 | |
| Domain | FYrich_C | 4.25e-04 | 5 | 123 | 2 | IPR003889 | |
| Domain | FYrich_N | 4.25e-04 | 5 | 123 | 2 | IPR003888 | |
| Domain | FYRC | 4.25e-04 | 5 | 123 | 2 | SM00542 | |
| Domain | FYRN | 4.25e-04 | 5 | 123 | 2 | SM00541 | |
| Domain | - | 4.25e-04 | 5 | 123 | 2 | 2.60.40.1260 | |
| Domain | WHIM1_dom | 4.25e-04 | 5 | 123 | 2 | IPR028942 | |
| Domain | Lamin_tail_dom | 4.25e-04 | 5 | 123 | 2 | IPR001322 | |
| Domain | LTD | 4.25e-04 | 5 | 123 | 2 | PF00932 | |
| Domain | WHIM1 | 4.25e-04 | 5 | 123 | 2 | PF15612 | |
| Domain | FYRN | 4.25e-04 | 5 | 123 | 2 | PF05964 | |
| Domain | FYRC | 4.25e-04 | 5 | 123 | 2 | PF05965 | |
| Domain | FYRC | 4.25e-04 | 5 | 123 | 2 | PS51543 | |
| Domain | FYRN | 4.25e-04 | 5 | 123 | 2 | PS51542 | |
| Domain | Znf_FYVE_PHD | 4.28e-04 | 147 | 123 | 6 | IPR011011 | |
| Domain | ZF_PHD_1 | 4.33e-04 | 96 | 123 | 5 | PS01359 | |
| Domain | DDT | 6.34e-04 | 6 | 123 | 2 | PS50827 | |
| Domain | FERM_C | 6.49e-04 | 26 | 123 | 3 | PF09380 | |
| Domain | FERM_PH-like_C | 7.26e-04 | 27 | 123 | 3 | IPR018980 | |
| Domain | FERM_C | 7.26e-04 | 27 | 123 | 3 | SM01196 | |
| Domain | Vinculin/catenin | 8.84e-04 | 7 | 123 | 2 | IPR006077 | |
| Domain | Plakophilin/d_Catenin | 8.84e-04 | 7 | 123 | 2 | IPR028435 | |
| Domain | CH | 8.89e-04 | 65 | 123 | 4 | SM00033 | |
| Domain | - | 1.17e-03 | 8 | 123 | 2 | 3.30.890.10 | |
| Domain | ACTINS_1 | 1.17e-03 | 8 | 123 | 2 | PS00406 | |
| Domain | CH | 1.17e-03 | 70 | 123 | 4 | PF00307 | |
| Domain | - | 1.24e-03 | 71 | 123 | 4 | 1.10.418.10 | |
| Domain | CH | 1.37e-03 | 73 | 123 | 4 | PS50021 | |
| Domain | RuvA_2-like | 1.50e-03 | 9 | 123 | 2 | IPR010994 | |
| Domain | CH-domain | 1.52e-03 | 75 | 123 | 4 | IPR001715 | |
| Domain | IG_FLMN | 1.87e-03 | 10 | 123 | 2 | SM00557 | |
| Domain | - | 1.87e-03 | 10 | 123 | 2 | 3.40.47.10 | |
| Domain | Thiolase-like | 1.87e-03 | 10 | 123 | 2 | IPR016039 | |
| Domain | Filamin | 2.28e-03 | 11 | 123 | 2 | PF00630 | |
| Domain | ZF_CXXC | 2.28e-03 | 11 | 123 | 2 | PS51058 | |
| Domain | FILAMIN_REPEAT | 2.28e-03 | 11 | 123 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 2.28e-03 | 11 | 123 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 2.28e-03 | 11 | 123 | 2 | IPR017868 | |
| Domain | MBD | 2.28e-03 | 11 | 123 | 2 | SM00391 | |
| Domain | MBD | 2.28e-03 | 11 | 123 | 2 | PS50982 | |
| Domain | Znf_CXXC | 2.28e-03 | 11 | 123 | 2 | IPR002857 | |
| Domain | Methyl_CpG_DNA-bd | 2.28e-03 | 11 | 123 | 2 | IPR001739 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 2.18e-07 | 96 | 93 | 8 | MM14592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAB_C_D_TO_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 2.18e-07 | 9 | 93 | 4 | M47725 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 4.95e-07 | 73 | 93 | 7 | MM15126 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 6.96e-06 | 41 | 93 | 5 | MM15630 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 8.23e-06 | 155 | 93 | 8 | M522 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 1.19e-05 | 117 | 93 | 7 | M19248 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 4.27e-05 | 30 | 93 | 4 | M47724 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 1.35e-04 | 40 | 93 | 4 | MM15060 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 1.64e-04 | 42 | 93 | 4 | M41821 | |
| Pathway | WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS | 1.97e-04 | 44 | 93 | 4 | M39673 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 2.11e-04 | 18 | 93 | 3 | MM15123 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 2.11e-04 | 18 | 93 | 3 | M840 | |
| Pathway | KEGG_TIGHT_JUNCTION | 2.35e-04 | 132 | 93 | 6 | M11355 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 2.77e-04 | 48 | 93 | 4 | MM15069 | |
| Pathway | WP_FOCAL_ADHESION | 3.42e-04 | 199 | 93 | 7 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.42e-04 | 199 | 93 | 7 | M7253 | |
| Pathway | PID_CASPASE_PATHWAY | 3.50e-04 | 51 | 93 | 4 | M220 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANXA2_S100A10_REGULATED_ACTIN_CYTOSKELETON | 4.25e-04 | 5 | 93 | 2 | M49034 | |
| Pathway | BIOCARTA_HIVNEF_PATHWAY | 5.02e-04 | 56 | 93 | 4 | M13968 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 5.74e-04 | 58 | 93 | 4 | M11980 | |
| Pubmed | RAD51B FAM184B FLNB FLNC SCN11A SPAG1 ELOA2 KRT18 KDM5A KTN1 ACTB RSF1 NUMA1 ACTG1 CHD2 LMNB2 SRBD1 EPB41L3 MECP2 SH3D21 RYR2 ABCB1 MEN1 UTP18 LMNB1 PALM KMT2A ACIN1 MACF1 IFT122 SPAG17 RAB1A | 1.67e-16 | 1442 | 129 | 32 | 35575683 | |
| Pubmed | FLNB FLNC TRIM25 CHMP5 KTN1 ATG2B NUMA1 UFL1 LMNB2 EPB41L3 RUFY1 IKBIP AKAP12 LMNB1 TLN1 RAB1A GCN1 EPB41 GOLGA4 CDK2 | 3.56e-14 | 568 | 129 | 20 | 37774976 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNB FLNC TRIM25 KRT18 ACAT2 KTN1 PSMB1 ACTB RSF1 NUMA1 CHD2 LMNB2 SRBD1 EPB41L3 MELK RIF1 UTP18 LMNB1 BAZ2A AIFM1 TLN1 ACIN1 MACF1 CTNND1 GCN1 UTRN GOLGA4 EPB41L2 | 9.93e-14 | 1353 | 129 | 28 | 29467282 |
| Pubmed | FLNB ABR CHMP5 KTN1 ATG2B NUMA1 MTMR1 MPDZ EPB41L3 LANCL2 AKAP12 LMNB1 AIFM1 TLN1 UBA6 MACF1 CTNND1 GCN1 EPB41 GOLGA4 EPB41L2 | 2.13e-13 | 708 | 129 | 21 | 39231216 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLNB TRIM25 KTN1 PSMB1 KIAA0586 NUMA1 ACTG1 UFL1 LMNB2 EPB41L3 LANCL2 YARS1 RIF1 UTP18 LMNB1 AIFM1 TLN1 ENAH CD47 UBA6 ACIN1 TLN2 CTNND1 RAB1A GCN1 GOLGA4 EPB41L2 CDK2 | 3.49e-13 | 1425 | 129 | 28 | 30948266 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TRIM25 KRT18 CDKN2AIP KTN1 RSF1 ATG2B NUMA1 EPB41L3 AKAP12 RIF1 BAZ2A TLN1 ENAH KMT2A ACIN1 MACF1 CTNND1 GCN1 UTRN EPB41 EPB41L2 CDK2 | 5.14e-12 | 934 | 129 | 22 | 33916271 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNB FLNC TRIM25 KRT18 NUMA1 ACTG1 UFL1 LMNB2 ITPRID2 ABCB1 RIF1 LMNB1 AIFM1 TLN1 UBA6 ACIN1 MACF1 CTNND1 RAB1A GCN1 UTRN EPB41L2 | 3.03e-11 | 1024 | 129 | 22 | 24711643 |
| Pubmed | FAM184B CCPG1 TRIM25 KTN1 MTMR1 MPDZ UFL1 LMNB2 ITPRID2 EPB41L3 IKBIP AKAP12 UTP18 LMNB1 BAZ2A AIFM1 TLN1 CCDC138 UBA6 PALM MACF1 IFT122 CTNND1 PIBF1 GOLGA4 EPB41L2 | 3.67e-11 | 1487 | 129 | 26 | 33957083 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | FLNB SPAG1 TRIM25 COL17A1 KRT18 CHMP5 KTN1 ITGA6 ITPRID2 EPB41L3 TLN1 MACF1 CTNND1 RAB1A GCN1 UTRN EPB41 | 3.98e-11 | 565 | 129 | 17 | 25468996 |
| Pubmed | FLNB FLNC RSF1 NUMA1 CHD2 LMNB2 EPB41L3 RIF1 UTP18 BAZ2A TLN1 ATAD2B KMT2A ACIN1 MACF1 GCN1 UTRN EPB41L2 | 4.24e-11 | 653 | 129 | 18 | 22586326 | |
| Pubmed | ABR KDM5A KTN1 ACTB NUMA1 MPDZ LMNB2 EPB41L3 BCR AKAP12 LMNB1 ENAH STON2 UBA6 MACF1 TLN2 CTNND1 CTNND2 RAB1A GOLGA4 EPB41L2 | 6.84e-11 | 963 | 129 | 21 | 28671696 | |
| Pubmed | FLNB FLNC KRT18 KTN1 ACTB NUMA1 LMNB2 YARS1 AKAP12 TLN1 ACIN1 MACF1 UTRN GOLGA4 | 8.40e-11 | 360 | 129 | 14 | 33111431 | |
| Pubmed | FLNB KMT2B CDKN2AIP KTN1 ACTB ACTG1 UFL1 LMNB2 YARS1 LMNB1 TLN1 KMT2A ACIN1 MACF1 CTNND1 RAB1A GCN1 UTRN | 1.68e-10 | 711 | 129 | 18 | 33022573 | |
| Pubmed | DDX19B ABR RBM33 PSMB1 NUMA1 MPDZ LMNB2 EPB41L3 BCR MECP2 RIF1 TLN1 ENAH KMT2A CTNND1 RAB1A GCN1 UTRN GOLGA4 EPB41L2 | 1.99e-10 | 916 | 129 | 20 | 32203420 | |
| Pubmed | KMT2B KTN1 ATG2B NUMA1 ACTG1 MPDZ RUFY1 LMNB1 BAZ2A TLN1 ENAH KMT2A ACIN1 CTNND1 GCN1 EPB41 | 2.47e-10 | 549 | 129 | 16 | 38280479 | |
| Pubmed | FLNB TRIM25 ACAT2 CHMP5 PSMB1 RSF1 ATG2B SRBD1 EPB41L3 MECP2 MEN1 TLN1 CCDC138 KMT2A PIBF1 UTRN EPB41 | 3.05e-10 | 645 | 129 | 17 | 25281560 | |
| Pubmed | FLNB NUMA1 UFL1 LMNB2 ITPRID2 EPB41L3 LMNB1 AIFM1 MACF1 EPB41 EPB41L2 | 3.14e-10 | 204 | 129 | 11 | 25659154 | |
| Pubmed | FLNB TRIM25 KRT18 PSMB1 ACTB NUMA1 ACTG1 LMNB2 ITPRID2 MEN1 LMNB1 AIFM1 PALM ACIN1 MACF1 CTNND1 EPB41L2 | 4.32e-10 | 660 | 129 | 17 | 32780723 | |
| Pubmed | FLNB FLNC TRIM25 KTN1 ACTB ACTG1 MTMR1 EPB41L3 BCR LANCL2 MECP2 YARS1 TLN1 STON2 MTMR2 PALM KMT2A MACF1 TLN2 CTNND1 CTNND2 RAB1A UTRN EPB41L2 | 5.37e-10 | 1431 | 129 | 24 | 37142655 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNB FLNC CCPG1 TRIM25 KTN1 PSMB1 ACTB NUMA1 HIVEP3 LMNB1 AIFM1 TLN1 KMT2A MACF1 SPAG17 RAB1A GCN1 UTRN | 1.25e-09 | 807 | 129 | 18 | 30575818 |
| Pubmed | TRIM25 KMT2B KDM5A RBM33 CDKN2AIP KTN1 ACTB MPDZ UFL1 CHD2 ITPRID2 SRBD1 MECP2 MEN1 HARS2 RIF1 BAZ2A TLN1 KMT2A MACF1 CTNND2 UTRN EPB41 EPB41L2 | 1.31e-09 | 1497 | 129 | 24 | 31527615 | |
| Pubmed | FLNB TRIM25 KRT18 RBM33 CDKN2AIP KTN1 PSMB1 ACTB NUMA1 RIF1 KRT24 TLN1 MACF1 UTRN EPB41 | 1.70e-09 | 538 | 129 | 15 | 28524877 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DDX19B KRT18 KDM5A MPDZ ITPRID2 EPB41L3 BCR MELK CCDC138 KMT2A MACF1 CTNND1 PIBF1 UTRN EPB41 GOLGA4 EPB41L2 TPD52L1 | 3.44e-09 | 861 | 129 | 18 | 36931259 |
| Pubmed | Identification of an FMNL2 Interactome by Quantitative Mass Spectrometry. | 6.40e-09 | 106 | 129 | 8 | 38891874 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | FLNB FLNC SPAG1 KRT18 KTN1 PSMB1 ITGA6 EPB41L3 IKBIP AKAP12 UTP18 LMNB1 AIFM1 HEBP1 TLN1 UBA6 ACIN1 RAB1A GCN1 UTRN EPB41 CDK2 | 6.56e-09 | 1367 | 129 | 22 | 32687490 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FLNB TRIM25 COL17A1 KRT18 ACTB NUMA1 ITGA6 LMNB2 ITPRID2 SRBD1 LANCL2 MECP2 IKBIP YARS1 HARS2 UTP18 LMNB1 STON2 ACIN1 CTNND1 EPB41L2 | 7.93e-09 | 1257 | 129 | 21 | 36526897 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | FLNB TRIM25 KRT18 KTN1 PSMB1 ACTB NUMA1 ACTG1 UFL1 LANCL2 YARS1 RIF1 AIFM1 TLN1 ENAH UBA6 MACF1 CTNND1 GCN1 GOLGA4 EPB41L2 CDK2 | 1.22e-08 | 1415 | 129 | 22 | 28515276 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | KMT2B MLX KRT18 KDM5A KTN1 ACTB NUMA1 ACTG1 CHD2 LMNB2 SRBD1 FANCM MECP2 IKBIP MEN1 RIF1 UTP18 LMNB1 BAZ2A KMT2A ACIN1 | 1.31e-08 | 1294 | 129 | 21 | 30804502 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | KRT18 RBM33 CDKN2AIP KTN1 ACTB RSF1 NUMA1 ACTG1 EPB41L3 FANCM MECP2 RIF1 LMNB1 BAZ2A ATAD2B KMT2A ACIN1 EPB41 | 1.67e-08 | 954 | 129 | 18 | 36373674 |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 2.00e-08 | 235 | 129 | 10 | 28378594 | |
| Pubmed | RBM33 CHMP5 SRBD1 MECP2 STK10 RIF1 LMNB1 MACF1 TLN2 CTNND1 EPB41 GOLGA4 CDK2 | 2.54e-08 | 472 | 129 | 13 | 38943005 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RAD51B FLNB EOGT ABR CHMP5 FRMPD1 CHD2 BCR HIVEP3 STK10 MALT1 ZNF532 ENAH UBA6 LRP5 MACF1 IFT122 DENND5A CTNND1 UTRN EPB41 GOLGA4 | 3.01e-08 | 1489 | 129 | 22 | 28611215 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KMT2B KDM5A NUMA1 UFL1 ITPRID2 MECP2 STK10 RIF1 UTP18 BAZ2A KMT2A ACIN1 TLN2 GOLGA4 EPB41L2 CDK2 | 3.20e-08 | 774 | 129 | 16 | 15302935 |
| Pubmed | FLNB KTN1 ANXA8L1 ATG2B ANXA8 PALMD EPB41L3 BCR YARS1 RYR2 ENAH PALM MACF1 TLN2 CTNND1 CTNND2 GCN1 EPB41 EPB41L2 | 4.53e-08 | 1139 | 129 | 19 | 36417873 | |
| Pubmed | Protein 4.1 expression in the developing hair cells of the mouse inner ear. | 4.99e-08 | 3 | 129 | 3 | 19853587 | |
| Pubmed | NuMA interacts with phosphoinositides and links the mitotic spindle with the plasma membrane. | 4.99e-08 | 3 | 129 | 3 | 24996901 | |
| Pubmed | Distinct pathways regulated by menin and by MLL1 in hematopoietic stem cells and developing B cells. | 4.99e-08 | 3 | 129 | 3 | 23908472 | |
| Pubmed | 4.99e-08 | 3 | 129 | 3 | 12239178 | ||
| Pubmed | 4.99e-08 | 3 | 129 | 3 | 22429617 | ||
| Pubmed | KRT18 CDKN2AIP ACTB ITGA6 ACTG1 MTMR1 ITPRID2 RIF1 AIFM1 ENAH CCDC138 MTMR2 PALM CTNND1 PIBF1 GCN1 UTRN GOLGA4 | 6.97e-08 | 1049 | 129 | 18 | 27880917 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | DDX19B FLNB FLNC KRT18 ACAT2 CHMP5 KTN1 PSMB1 ACTG1 RUFY1 YARS1 AKAP12 LMNB1 TLN1 ENAH MTMR2 UBA6 MACF1 RAB1A GCN1 EPB41L2 | 9.57e-08 | 1455 | 129 | 21 | 22863883 |
| Pubmed | FLNB FLNC TRIM25 KRT18 PSMB1 RSF1 ACTG1 LANCL2 YARS1 LMNB1 TLN1 MACF1 CTNND1 CTNND2 GCN1 UTRN | 1.04e-07 | 844 | 129 | 16 | 25963833 | |
| Pubmed | ELOA2 TRIM25 PSMB1 KIAA0586 SRBD1 MECP2 LMNB1 ENAH KMT2A MACF1 | 1.07e-07 | 281 | 129 | 10 | 24163370 | |
| Pubmed | 1.20e-07 | 215 | 129 | 9 | 35973513 | ||
| Pubmed | 1.22e-07 | 285 | 129 | 10 | 21423176 | ||
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 1.41e-07 | 219 | 129 | 9 | 31353912 | |
| Pubmed | TRIM25 KDM5A KTN1 NUMA1 CHD2 MECP2 IKBIP ANKRD36B HARS2 RIF1 LMNB1 AIFM1 TLN1 STON2 KMT2A ACIN1 CTNND1 RAB1A GCN1 EPB41L2 | 1.69e-07 | 1371 | 129 | 20 | 36244648 | |
| Pubmed | DDX19B FLNB ACAT2 ACTG1 EPB41L3 LANCL2 YARS1 AKAP12 LMNB1 AIFM1 TLN1 RAB1A GCN1 EPB41 EPB41L2 CDK2 | 1.78e-07 | 878 | 129 | 16 | 37223481 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | FLNB FLNC KRT18 PSMB1 ACTB ACTG1 YARS1 AIFM1 PALM IFT122 RAB1A GCN1 GOLGA4 | 1.98e-07 | 564 | 129 | 13 | 21565611 |
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 15834631 | ||
| Pubmed | GGA2 CCDC186 EPB41L3 RUFY1 AKAP12 RYR2 RIF1 FAT1 UTP18 LMNB1 CTNND1 GCN1 EPB41 GOLGA4 EPB41L2 | 2.13e-07 | 777 | 129 | 15 | 35844135 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | SPAG1 COL17A1 ITGA6 MTMR1 ABCB1 STK10 FAT1 STON2 PALM CTNND1 RAB1A EPB41 EPB41L2 | 2.19e-07 | 569 | 129 | 13 | 30639242 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DDX19B CDKN2AIP ACTB EPB41L3 MELK RIF1 TLN1 ENAH ACIN1 MACF1 TLN2 CTNND1 GCN1 | 2.83e-07 | 582 | 129 | 13 | 20467437 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 2.89e-07 | 313 | 129 | 10 | 38270169 | |
| Pubmed | FLNC KRT18 RBM33 CCDC186 KTN1 ITPRID2 EPB41L3 RIF1 MACF1 PIBF1 GCN1 EPB41L2 | 2.89e-07 | 486 | 129 | 12 | 20936779 | |
| Pubmed | FLNB CCPG1 EOGT KRT18 ACTB NUMA1 ACTG1 UFL1 MELK LANCL2 IKBIP YARS1 AKAP12 FAT1 AIFM1 MACF1 RAB1A EPB41L2 CDK2 | 3.35e-07 | 1297 | 129 | 19 | 33545068 | |
| Pubmed | 4.44e-07 | 251 | 129 | 9 | 27507650 | ||
| Pubmed | A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. | 4.55e-07 | 125 | 129 | 7 | 21654808 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | KMT2B KDM5A RSF1 NUMA1 CHD2 SRBD1 LANCL2 MECP2 MEN1 RIF1 BAZ2A ATAD2B KMT2A | 4.64e-07 | 608 | 129 | 13 | 36089195 |
| Pubmed | MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia. | 4.96e-07 | 5 | 129 | 3 | 28609655 | |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 5.31e-07 | 18 | 129 | 4 | 12119179 | |
| Pubmed | ITGA6 MTMR1 UFL1 AKAP12 STK10 MTMR2 PALM MACF1 CTNND1 UTRN EPB41L2 | 5.32e-07 | 421 | 129 | 11 | 36976175 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | FLNC TRIM25 ABR KDM5A RBM33 CHMP5 KTN1 EPB41L3 BCR AKAP12 TLN1 MACF1 CTNND1 GCN1 | 5.46e-07 | 724 | 129 | 14 | 36232890 |
| Pubmed | 8.79e-07 | 47 | 129 | 5 | 32253237 | ||
| Pubmed | 9.15e-07 | 87 | 129 | 6 | 12465718 | ||
| Pubmed | Dual regulation of neuronal morphogenesis by a delta-catenin-cortactin complex and Rho. | 9.89e-07 | 6 | 129 | 3 | 12835311 | |
| Pubmed | MLL associates specifically with a subset of transcriptionally active target genes. | 9.89e-07 | 6 | 129 | 3 | 16199523 | |
| Pubmed | 9.89e-07 | 6 | 129 | 3 | 12679033 | ||
| Pubmed | ACAT2 CHMP5 EPB41L3 RUFY1 AKAP12 TLN1 CTNND1 GCN1 UTRN EPB41 EPB41L2 | 9.98e-07 | 449 | 129 | 11 | 31732153 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | SPAG1 KRT18 KDM5A ACTB NUMA1 ITPRID2 DSN1 RIF1 ACIN1 EPB41L2 | 1.06e-06 | 361 | 129 | 10 | 30344098 |
| Pubmed | GGA2 RBM33 CDKN2AIP CHMP5 KTN1 ITPRID2 DSN1 IKBIP AKAP12 LMNB1 HEBP1 ENAH CCDC138 CTNND1 EPB41 EPB41L2 | 1.09e-06 | 1007 | 129 | 16 | 34597346 | |
| Pubmed | 1.12e-06 | 90 | 129 | 6 | 31280863 | ||
| Pubmed | TRIM25 CDKN2AIP PSMB1 RSF1 NUMA1 UFL1 CHD2 LMNB2 YARS1 RIF1 ZNF532 UBA6 KMT2A ACIN1 CTNND1 CDK2 | 1.19e-06 | 1014 | 129 | 16 | 32416067 | |
| Pubmed | 1.22e-06 | 209 | 129 | 8 | 36779422 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FLNB FLNC KRT18 ACAT2 PSMB1 ACTB MTMR1 MPDZ YARS1 AKAP12 TLN1 ENAH MACF1 RAB1A GCN1 EPB41L2 TPD52L1 | 1.29e-06 | 1149 | 129 | 17 | 35446349 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | DDX19B TRAF6 KRT18 ACAT2 CHMP5 PSMB1 UFL1 EPB41L3 YARS1 MEN1 MALT1 AIFM1 ACIN1 GCN1 KRT36 EPB41 EPB41L2 CDK2 | 1.32e-06 | 1284 | 129 | 18 | 17353931 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ABR CCDC186 CHD2 ANKRD36C BCR ANKRD36B STK10 AIFM1 TLN1 CCDC138 STON2 KMT2A CTNND1 UTRN CDK2 | 1.54e-06 | 910 | 129 | 15 | 36736316 |
| Pubmed | Cortical dynein and asymmetric membrane elongation coordinately position the spindle in anaphase. | 1.73e-06 | 7 | 129 | 3 | 23870127 | |
| Pubmed | 1.73e-06 | 7 | 129 | 3 | 35780119 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | FLNB FLNC ACTB NUMA1 ITGA6 LMNB2 LMNB1 AIFM1 TLN1 ACIN1 GCN1 | 1.79e-06 | 477 | 129 | 11 | 31300519 |
| Pubmed | FLNB FLNC TRIM25 KTN1 ACTB ABCB1 LMNB1 TLN1 CD47 CTNND1 EPB41L2 | 2.06e-06 | 484 | 129 | 11 | 31995728 | |
| Pubmed | FLNB FLNC KRT18 PSMB1 ACTB ACTG1 KRT24 TLN1 MACF1 CTNND1 GCN1 | 2.23e-06 | 488 | 129 | 11 | 31324722 | |
| Pubmed | KTN1 ITGA6 ACTG1 LMNB2 EPB41L3 AKAP12 FAT1 UTP18 LMNB1 AIFM1 CTNND1 RAB1A EPB41 GOLGA4 EPB41L2 | 2.67e-06 | 952 | 129 | 15 | 38569033 | |
| Pubmed | 2.75e-06 | 8 | 129 | 3 | 7983158 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | NUMA1 LMNB2 YARS1 LMNB1 AIFM1 TLN1 UBA6 ACIN1 CTNND1 RAB1A GCN1 EPB41L2 | 2.94e-06 | 607 | 129 | 12 | 39147351 |
| Pubmed | FLNB RSF1 NUMA1 EPB41L3 STK10 RIF1 UTP18 ENAH ACIN1 TLN2 EPB41L2 | 2.98e-06 | 503 | 129 | 11 | 16964243 | |
| Pubmed | 3.15e-06 | 506 | 129 | 11 | 30890647 | ||
| Pubmed | 3.29e-06 | 320 | 129 | 9 | 28685749 | ||
| Pubmed | 3.36e-06 | 411 | 129 | 10 | 36652389 | ||
| Pubmed | 3.90e-06 | 418 | 129 | 10 | 34709266 | ||
| Pubmed | 4.12e-06 | 9 | 129 | 3 | 15199122 | ||
| Pubmed | 4.12e-06 | 9 | 129 | 3 | 11807098 | ||
| Pubmed | 4.12e-06 | 9 | 129 | 3 | 22976293 | ||
| Pubmed | 4.33e-06 | 248 | 129 | 8 | 32963011 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 4.44e-06 | 332 | 129 | 9 | 32786267 | |
| Pubmed | FLNB RBM33 PSMB1 ACTB UFL1 LMNB2 RIF1 LMNB1 AIFM1 TLN1 GCN1 EPB41L2 | 4.87e-06 | 638 | 129 | 12 | 33239621 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | DDX19B FLNB FLNC KRT18 KTN1 MPDZ SRBD1 BCR MELK LANCL2 UTP18 CTNND1 GCN1 UTRN KRT36 | 5.14e-06 | 1005 | 129 | 15 | 19615732 |
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 5.43e-06 | 118 | 129 | 6 | 27377895 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 5.47e-06 | 256 | 129 | 8 | 33397691 | |
| Pubmed | FBP WW domains and the Abl SH3 domain bind to a specific class of proline-rich ligands. | 5.87e-06 | 10 | 129 | 3 | 9171351 | |
| Interaction | KCNA3 interactions | FLNB ABR CHMP5 KTN1 ATG2B NUMA1 MTMR1 MPDZ CHD2 EPB41L3 LANCL2 AKAP12 LMNB1 AIFM1 TLN1 UBA6 KMT2A MACF1 TLN2 CTNND1 GCN1 EPB41 GOLGA4 EPB41L2 NLRP5 | 1.18e-10 | 871 | 125 | 25 | int:KCNA3 |
| Interaction | RHOF interactions | DDX19B TRIM25 ACTB ITGA6 MTMR1 MPDZ LMNB2 EPB41L3 MELK YARS1 AKAP12 STK10 FAT1 UTP18 LMNB1 STON2 PALM MACF1 RAB1A UTRN EPB41 | 1.00e-09 | 673 | 125 | 21 | int:RHOF |
| Interaction | RAC2 interactions | KTN1 ACTB ITGA6 MTMR1 UFL1 LMNB2 RUFY1 MELK LANCL2 AKAP12 FAT1 LMNB1 STON2 PALM LRP5 MACF1 TLN2 CTNND1 RAB1A UTRN GOLGA4 | 1.03e-09 | 674 | 125 | 21 | int:RAC2 |
| Interaction | RAC1 interactions | FLNB TRAF6 ABR KTN1 ACTB ITGA6 MTMR1 LMNB2 EPB41L3 BCR RUFY1 MELK YARS1 AKAP12 STK10 FAT1 LMNB1 ENAH STON2 PALM LRP5 MACF1 CTNND1 RAB1A UTRN CDK2 | 1.46e-09 | 1063 | 125 | 26 | int:RAC1 |
| Interaction | NAA40 interactions | TRIM25 KRT18 CDKN2AIP KTN1 ACTB RSF1 ATG2B NUMA1 EPB41L3 MECP2 AKAP12 RIF1 BAZ2A TLN1 ENAH KMT2A ACIN1 MACF1 CTNND1 GCN1 UTRN EPB41 EPB41L2 CDK2 | 6.54e-09 | 978 | 125 | 24 | int:NAA40 |
| Interaction | BIRC3 interactions | FLNB TRAF6 KTN1 PSMB1 KIAA0586 NUMA1 ACTG1 UFL1 LMNB2 LANCL2 YARS1 RIF1 UTP18 LMNB1 AIFM1 TLN1 ENAH CD47 UBA6 ACIN1 TLN2 CTNND1 RAB1A GCN1 GOLGA4 EPB41L2 CDK2 | 3.74e-08 | 1334 | 125 | 27 | int:BIRC3 |
| Interaction | CCDC8 interactions | FLNB TRIM25 KRT18 NUMA1 ACTG1 UFL1 LMNB2 ITPRID2 LMNB1 AIFM1 UBA6 MACF1 CTNND1 RAB1A GCN1 UTRN CDH5 EPB41L2 | 1.24e-07 | 656 | 125 | 18 | int:CCDC8 |
| Interaction | RHOC interactions | KTN1 ITGA6 LMNB2 BCR STK10 FAT1 UTP18 LMNB1 STON2 PALM KMT2A MACF1 CTNND1 RAB1A UTRN GOLGA4 CDK2 | 1.25e-07 | 584 | 125 | 17 | int:RHOC |
| Interaction | SIRT7 interactions | FLNB FLNC TRIM25 RSF1 NUMA1 CHD2 LMNB2 EPB41L3 RIF1 UTP18 BAZ2A TLN1 ATAD2B KMT2A ACIN1 MACF1 GCN1 UTRN EPB41L2 | 1.63e-07 | 744 | 125 | 19 | int:SIRT7 |
| Interaction | MYH9 interactions | FLNB TRAF6 TRIM25 ACTB ACTG1 UFL1 HMGCS2 ITPRID2 RUFY1 MECP2 DSN1 MEN1 TLN1 STON2 MACF1 EPB41 GOLGA4 EPB41L2 CDK2 | 2.01e-07 | 754 | 125 | 19 | int:MYH9 |
| Interaction | WDR5 interactions | FLNB TRAF6 KMT2B KRT18 KDM5A CDKN2AIP KTN1 ACTB ACTG1 MTMR1 UFL1 LMNB2 YARS1 MEN1 LMNB1 TLN1 KMT2A ACIN1 MACF1 CTNND1 RAB1A GCN1 UTRN | 2.63e-07 | 1101 | 125 | 23 | int:WDR5 |
| Interaction | CDH1 interactions | FLNB SPAG1 TRIM25 COL17A1 KRT18 CHMP5 KTN1 ITGA6 ACTG1 ITPRID2 EPB41L3 TLN1 MACF1 CTNND1 CTNND2 RAB1A GCN1 UTRN EPB41 | 2.66e-07 | 768 | 125 | 19 | int:CDH1 |
| Interaction | RHOA interactions | ABR KTN1 ITGA6 MTMR1 UFL1 LMNB2 EPB41L3 BCR RUFY1 YARS1 AKAP12 STK10 FAT1 UTP18 LMNB1 STON2 PALM LRP5 MACF1 CTNND1 RAB1A GCN1 UTRN GOLGA4 | 3.01e-07 | 1199 | 125 | 24 | int:RHOA |
| Interaction | YWHAQ interactions | TRAF6 TRIM25 KRT18 ACTB NUMA1 ACTG1 UFL1 HMGCS2 ITPRID2 EPB41L3 BCR RUFY1 MELK LMNB1 TLN1 KMT2A MACF1 CTNND1 GCN1 EPB41 EPB41L2 CDK2 TPD52L1 | 3.44e-07 | 1118 | 125 | 23 | int:YWHAQ |
| Interaction | CSNK2A1 interactions | ABR KMT2B MLX ACAT2 RBM33 RSF1 MTMR1 ANKRD36C SRBD1 EPB41L3 BCR MECP2 MEN1 ANKRD36B UTP18 BRF1 KMT2A ACIN1 MACF1 EPB41L2 CDK2 | 4.16e-07 | 956 | 125 | 21 | int:CSNK2A1 |
| Interaction | RHOD interactions | TRIM25 KTN1 ITGA6 MTMR1 LMNB2 EPB41L3 RUFY1 AKAP12 LMNB1 STON2 MACF1 CTNND1 RAB1A UTRN EPB41 GOLGA4 | 5.15e-07 | 572 | 125 | 16 | int:RHOD |
| Interaction | FLNA interactions | FLNB FLNC ACTB ACTG1 UFL1 CHD2 ITPRID2 RUFY1 IKBIP YARS1 AKAP12 AIFM1 STON2 PALM RAB1A EPB41 CDK2 | 5.38e-07 | 648 | 125 | 17 | int:FLNA |
| Interaction | PPIA interactions | FLNC TRIM25 RBM33 CHMP5 ACTB UFL1 ANKRD36C SRBD1 MECP2 STK10 RIF1 LMNB1 AIFM1 HEBP1 MACF1 TLN2 CTNND1 EPB41 GOLGA4 CDK2 | 5.51e-07 | 888 | 125 | 20 | int:PPIA |
| Interaction | MCM2 interactions | FLNB FLNC TRIM25 KRT18 PSMB1 RSF1 ATG2B NUMA1 ACTG1 BCR LANCL2 YARS1 MEN1 LMNB1 TLN1 KMT2A MACF1 CTNND1 CTNND2 GCN1 UTRN CDK2 | 7.72e-07 | 1081 | 125 | 22 | int:MCM2 |
| Interaction | YAP1 interactions | FLNB TRAF6 KMT2B ACTB NUMA1 ACTG1 MPDZ SH3D21 MEN1 LMNB1 BAZ2A AIFM1 TLN1 ENAH KMT2A ACIN1 CTNND1 RAB1A POU2F3 GCN1 EPB41 EPB41L2 | 9.56e-07 | 1095 | 125 | 22 | int:YAP1 |
| Interaction | NUPR1 interactions | FLNB TRIM25 KRT18 PSMB1 ACTB NUMA1 ACTG1 LMNB2 ITPRID2 MEN1 LMNB1 AIFM1 PALM ACIN1 MACF1 CTNND1 EPB41L2 | 1.11e-06 | 683 | 125 | 17 | int:NUPR1 |
| Interaction | KCTD13 interactions | FLNB FLNC TRIM25 KTN1 ACTB ACTG1 MTMR1 EPB41L3 BCR LANCL2 MECP2 YARS1 TLN1 STON2 MTMR2 PALM KMT2A MACF1 TLN2 CTNND1 CTNND2 RAB1A UTRN EPB41L2 CDK2 | 1.26e-06 | 1394 | 125 | 25 | int:KCTD13 |
| Interaction | WWTR1 interactions | TRIM25 KTN1 ATG2B NUMA1 MPDZ RUFY1 LMNB1 TLN1 ENAH KMT2A CTNND1 GCN1 EPB41 | 2.27e-06 | 422 | 125 | 13 | int:WWTR1 |
| Interaction | FMNL2 interactions | 2.33e-06 | 185 | 125 | 9 | int:FMNL2 | |
| Interaction | CAV1 interactions | TRAF6 KRT18 ACTB ITGA6 MTMR1 EPB41L3 RUFY1 AKAP12 ABCB1 STK10 PALM ACIN1 MACF1 CTNND1 UTRN EPB41 EPB41L2 | 2.45e-06 | 724 | 125 | 17 | int:CAV1 |
| Interaction | RAB35 interactions | SPAG1 ITGA6 MTMR1 EPB41L3 RUFY1 MECP2 AKAP12 LMNB1 PALM MACF1 CTNND1 RAB1A UTRN EPB41 EPB41L2 | 2.72e-06 | 573 | 125 | 15 | int:RAB35 |
| Interaction | PLEC interactions | DDX19B COL17A1 KRT18 ACTB ITGA6 ACTG1 FANCM MECP2 MALT1 LMNB1 AIFM1 MACF1 CDK2 | 2.79e-06 | 430 | 125 | 13 | int:PLEC |
| Interaction | PNN interactions | KRT18 RBM33 NUMA1 EPB41L3 BCR MECP2 MEN1 HIVEP3 ACIN1 EPB41L2 CDK2 | 2.91e-06 | 302 | 125 | 11 | int:PNN |
| Interaction | PPP1CC interactions | SPAG1 TRAF6 TRIM25 KRT18 KDM5A ACTB NUMA1 ACTG1 UFL1 ITPRID2 MECP2 DSN1 RYR2 RIF1 ACIN1 EPB41L2 CDK2 | 3.16e-06 | 738 | 125 | 17 | int:PPP1CC |
| Interaction | ACTA1 interactions | ACTB ACTG1 MTMR1 ANXA8 MECP2 TLN1 MACF1 CTNND1 UTRN EPB41 EPB41L2 CDK2 | 3.45e-06 | 371 | 125 | 12 | int:ACTA1 |
| Interaction | C11orf52 interactions | ITGA6 MPDZ EPB41L3 AKAP12 STON2 PALM MACF1 CTNND1 UTRN EPB41 EPB41L2 | 3.85e-06 | 311 | 125 | 11 | int:C11orf52 |
| Interaction | AIMP2 interactions | FLNB FLNC TRAF6 PSMB1 ACTB ACTG1 UFL1 DSN1 MEN1 HARS2 AIFM1 CTNND1 KRT36 | 4.15e-06 | 446 | 125 | 13 | int:AIMP2 |
| Interaction | NPM1 interactions | FAM184B FLNB FLNC TRAF6 GGA2 KRT18 KTN1 ACTB NUMA1 ACTG1 UFL1 RUFY1 MECP2 AKAP12 MEN1 MALT1 UTP18 LMNB1 KMT2A RAB1A UTRN CDK2 | 4.33e-06 | 1201 | 125 | 22 | int:NPM1 |
| Interaction | CDC42 interactions | FLNC KTN1 PSMB1 ACTB ITGA6 MTMR1 UFL1 LMNB2 EPB41L3 BCR RUFY1 MELK MECP2 YARS1 AKAP12 FAT1 LMNB1 AIFM1 STON2 LRP5 CTNND1 RAB1A UTRN | 6.03e-06 | 1323 | 125 | 23 | int:CDC42 |
| Interaction | H2BC21 interactions | RAG1 TRAF6 KMT2B RSF1 NUMA1 UFL1 SRBD1 EPB41L3 MELK MECP2 MEN1 RIF1 LMNB1 TLN1 KMT2A CDK2 | 6.49e-06 | 696 | 125 | 16 | int:H2BC21 |
| Interaction | DDB1 interactions | RAG1 FLNC TRAF6 TRIM25 PSMB1 ACTB RSF1 NUMA1 UFL1 EPB41L3 RUFY1 MECP2 YARS1 MEN1 AIFM1 RAB1A | 6.61e-06 | 697 | 125 | 16 | int:DDB1 |
| Interaction | RAC3 interactions | KTN1 ITGA6 MTMR1 LMNB2 EPB41L3 AKAP12 FAT1 LMNB1 STON2 PALM LRP5 MACF1 RAB1A UTRN GOLGA4 | 6.91e-06 | 619 | 125 | 15 | int:RAC3 |
| Interaction | NUMA1 interactions | RSF1 NUMA1 EPB41L3 MEN1 RIF1 TLN1 ATAD2B UBA6 KMT2A MACF1 EPB41 EPB41L2 CDK2 | 7.14e-06 | 469 | 125 | 13 | int:NUMA1 |
| Interaction | TES interactions | 7.17e-06 | 332 | 125 | 11 | int:TES | |
| Interaction | TMOD1 interactions | 7.43e-06 | 161 | 125 | 8 | int:TMOD1 | |
| Interaction | DNASE1 interactions | 8.01e-06 | 7 | 125 | 3 | int:DNASE1 | |
| Interaction | EZR interactions | TRIM25 ABR ACTB MTMR1 PALMD BCR MECP2 AKAP12 STK10 ENAH MACF1 CTNND1 UTRN EPB41 | 8.74e-06 | 553 | 125 | 14 | int:EZR |
| Interaction | ARRDC3 interactions | 1.10e-05 | 224 | 125 | 9 | int:ARRDC3 | |
| Interaction | DBN1 interactions | FLNB SCN11A ACTB ACTG1 ITPRID2 PALMD MECP2 BRF1 STON2 PALM RAB1A CDK2 | 1.13e-05 | 417 | 125 | 12 | int:DBN1 |
| Interaction | IMPDH2 interactions | TRIM25 ACTB ATG2B NUMA1 UFL1 RUFY1 MECP2 MEN1 AIFM1 UBA6 GOLGA4 CDK2 | 1.21e-05 | 420 | 125 | 12 | int:IMPDH2 |
| Interaction | RHOG interactions | TRIM25 KTN1 ITGA6 MTMR1 LMNB2 EPB41L3 RUFY1 AKAP12 HARS2 FAT1 LMNB1 STON2 PALM MACF1 CTNND1 RAB1A EPB41 GOLGA4 | 1.29e-05 | 910 | 125 | 18 | int:RHOG |
| Interaction | CAPZA2 interactions | FLNB TRIM25 KTN1 ACTB NUMA1 ACTG1 ITPRID2 MEN1 STON2 UBA6 MACF1 RAB1A | 1.53e-05 | 430 | 125 | 12 | int:CAPZA2 |
| Interaction | TXN interactions | FLNB KRT18 UFL1 RUFY1 MELK STK10 HARS2 AIFM1 RAB1A GOLGA4 CDK2 | 1.53e-05 | 360 | 125 | 11 | int:TXN |
| Interaction | PRKCD interactions | 1.79e-05 | 238 | 125 | 9 | int:PRKCD | |
| Interaction | AGR2 interactions | FLNB FLNC CCPG1 TRIM25 KTN1 PSMB1 ACTB NUMA1 HIVEP3 LMNB1 AIFM1 TLN1 KMT2A MACF1 SPAG17 RAB1A GCN1 UTRN | 1.83e-05 | 934 | 125 | 18 | int:AGR2 |
| Interaction | GOLGA1 interactions | 1.89e-05 | 183 | 125 | 8 | int:GOLGA1 | |
| Interaction | IQCB1 interactions | FLNB FLNC KRT18 PSMB1 ACTB ACTG1 AIFM1 IFT122 RAB1A GCN1 CDH5 | 1.97e-05 | 370 | 125 | 11 | int:IQCB1 |
| Interaction | FLNB interactions | 2.02e-05 | 304 | 125 | 10 | int:FLNB | |
| Interaction | VCL interactions | 2.08e-05 | 305 | 125 | 10 | int:VCL | |
| Interaction | KPNA2 interactions | RAG1 TRIM25 KRT18 NUMA1 UFL1 RUFY1 MECP2 MEN1 LMNB1 NPIPB6 EPB41 GOLGA4 CDK2 | 2.09e-05 | 519 | 125 | 13 | int:KPNA2 |
| Interaction | CASP4 interactions | 2.10e-05 | 54 | 125 | 5 | int:CASP4 | |
| Interaction | AMOT interactions | 2.53e-05 | 312 | 125 | 10 | int:AMOT | |
| Interaction | EFTUD2 interactions | FLNB TRIM25 KRT18 KTN1 ACTB NUMA1 ACTG1 UFL1 RUFY1 LANCL2 MECP2 YARS1 MEN1 RIF1 BRF1 AIFM1 TLN1 MACF1 CTNND1 GCN1 GOLGA4 EPB41L2 CDK2 | 2.61e-05 | 1449 | 125 | 23 | int:EFTUD2 |
| Interaction | WWC1 interactions | 2.63e-05 | 94 | 125 | 6 | int:WWC1 | |
| Interaction | CIT interactions | RAG1 FLNB FLNC KTN1 RSF1 NUMA1 CHD2 LMNB2 SRBD1 RIF1 UTP18 LMNB1 AIFM1 KMT2A ACIN1 MACF1 CTNND1 PIBF1 SPAG17 RAB1A GCN1 GOLGA4 NLRP5 | 2.64e-05 | 1450 | 125 | 23 | int:CIT |
| Interaction | HSP90AB1 interactions | TRAF6 TRIM25 KTN1 ACTB NUMA1 ITGA6 ACTG1 UFL1 CHD2 RUFY1 MECP2 TLN1 KMT2A ACIN1 SPAG17 RAB1A EPB41L2 CDK2 | 2.64e-05 | 960 | 125 | 18 | int:HSP90AB1 |
| Interaction | WDR76 interactions | FLNB KRT18 ACTB NUMA1 ACTG1 YARS1 LMNB1 AIFM1 GCN1 UTRN EPB41L2 | 2.71e-05 | 383 | 125 | 11 | int:WDR76 |
| Interaction | YWHAE interactions | TRIM25 MLX KRT18 ACAT2 KTN1 ACTB UFL1 ITPRID2 EPB41L3 BCR RUFY1 MELK LANCL2 LMNB1 MTMR2 KMT2A MACF1 CTNND1 EPB41 EPB41L2 CDK2 | 2.90e-05 | 1256 | 125 | 21 | int:YWHAE |
| Interaction | PHACTR2 interactions | 2.97e-05 | 29 | 125 | 4 | int:PHACTR2 | |
| Interaction | PRC1 interactions | FLNB FLNC TRIM25 OLFML2B KTN1 RSF1 NUMA1 LMNB2 MECP2 UTP18 BRF1 LMNB1 STON2 ACIN1 RAB1A GCN1 EPB41L2 CDK2 | 3.15e-05 | 973 | 125 | 18 | int:PRC1 |
| Interaction | HECW2 interactions | ELOA2 TRIM25 PSMB1 KIAA0586 SRBD1 MECP2 LMNB1 ENAH KMT2A MACF1 | 3.30e-05 | 322 | 125 | 10 | int:HECW2 |
| Interaction | NUP43 interactions | KMT2B KDM5A CDKN2AIP RSF1 ITPRID2 MECP2 RYR2 RIF1 LMNB1 ZNF532 BAZ2A ATAD2B KMT2A ACIN1 | 3.40e-05 | 625 | 125 | 14 | int:NUP43 |
| Interaction | PPP1CB interactions | FLNB TRIM25 ACTB NUMA1 ACTG1 ITPRID2 MECP2 RYR2 RIF1 STON2 RAB1A CDK2 | 3.59e-05 | 469 | 125 | 12 | int:PPP1CB |
| Interaction | ARHGAP27 interactions | 3.71e-05 | 11 | 125 | 3 | int:ARHGAP27 | |
| Interaction | KIF25 interactions | 3.82e-05 | 2 | 125 | 2 | int:KIF25 | |
| Interaction | RHOJ interactions | ITGA6 MTMR1 LMNB2 EPB41L3 YARS1 AKAP12 FAT1 UTP18 STON2 PALM LRP5 MACF1 RAB1A UTRN | 3.90e-05 | 633 | 125 | 14 | int:RHOJ |
| Interaction | TPM1 interactions | 3.92e-05 | 263 | 125 | 9 | int:TPM1 | |
| Interaction | SNRNP40 interactions | KMT2B CDKN2AIP RSF1 NUMA1 SRBD1 MECP2 MEN1 LMNB1 ZNF532 BAZ2A ATAD2B KMT2A ACIN1 EPB41L2 | 4.18e-05 | 637 | 125 | 14 | int:SNRNP40 |
| Interaction | SMC5 interactions | KRT18 RBM33 CDKN2AIP KTN1 ACTB RSF1 NUMA1 ACTG1 EPB41L3 FANCM MECP2 RIF1 LMNB1 BAZ2A ATAD2B KMT2A ACIN1 EPB41 | 4.50e-05 | 1000 | 125 | 18 | int:SMC5 |
| Interaction | ACLY interactions | 4.61e-05 | 335 | 125 | 10 | int:ACLY | |
| Interaction | NUDC interactions | FLNB FLNC TRIM25 KRT18 UFL1 ANKRD36C ZNF532 AIFM1 TLN1 EPB41L2 | 4.85e-05 | 337 | 125 | 10 | int:NUDC |
| Interaction | YWHAH interactions | KRT18 KDM5A CHMP5 MPDZ ITPRID2 EPB41L3 BCR MELK CCDC138 KMT2A MACF1 CTNND1 PIBF1 UTRN EPB41 GOLGA4 EPB41L2 CDK2 TPD52L1 | 4.85e-05 | 1102 | 125 | 19 | int:YWHAH |
| Interaction | ANXA8L1 interactions | 4.92e-05 | 12 | 125 | 3 | int:ANXA8L1 | |
| Interaction | CTNNB1 interactions | TRAF6 TRIM25 ACTB NUMA1 ACTG1 MPDZ AKAP12 MEN1 LMNB1 TLN1 CD47 KMT2A LRP5 CTNND1 CTNND2 UTRN CDH5 CDK2 | 5.05e-05 | 1009 | 125 | 18 | int:CTNNB1 |
| Interaction | HDAC1 interactions | FLNB KMT2B KDM5A ACTB ATG2B EPB41L3 BCR RUFY1 MECP2 MEN1 LMNB1 BAZ2A AIFM1 TLN1 KMT2A GCN1 UTRN GOLGA4 TPD52L1 | 5.22e-05 | 1108 | 125 | 19 | int:HDAC1 |
| Interaction | YWHAB interactions | TRIM25 MLX KRT18 PSMB1 ACTB ACTG1 ITPRID2 EPB41L3 BCR MELK LMNB1 KMT2A MACF1 CTNND1 PIBF1 EPB41 EPB41L2 TPD52L1 | 5.39e-05 | 1014 | 125 | 18 | int:YWHAB |
| Interaction | BAP1 interactions | FLNB FLNC KRT18 ACAT2 PSMB1 ACTB MTMR1 MPDZ LANCL2 IKBIP YARS1 AKAP12 FAT1 TLN1 ENAH MACF1 RAB1A GCN1 GOLGA4 EPB41L2 TPD52L1 | 5.60e-05 | 1314 | 125 | 21 | int:BAP1 |
| Interaction | SBF1 interactions | 5.63e-05 | 157 | 125 | 7 | int:SBF1 | |
| Interaction | COL17A1 interactions | 5.66e-05 | 34 | 125 | 4 | int:COL17A1 | |
| Interaction | RCOR1 interactions | TRIM25 KMT2B ACTB ATG2B NUMA1 EPB41L3 BCR RUFY1 MECP2 LMNB1 GCN1 UTRN | 5.91e-05 | 494 | 125 | 12 | int:RCOR1 |
| Interaction | YWHAZ interactions | TRIM25 MLX KRT18 RSF1 ACTG1 MTMR1 UFL1 ITPRID2 EPB41L3 BCR RUFY1 MELK KRT24 ENAH KMT2A MACF1 CTNND1 EPB41 EPB41L2 CDK2 TPD52L1 | 5.91e-05 | 1319 | 125 | 21 | int:YWHAZ |
| Interaction | SNW1 interactions | DDX19B RBM33 CDKN2AIP ACTB UFL1 MECP2 MEN1 STK10 RIF1 LMNB1 TLN1 ENAH KMT2A ACIN1 GCN1 | 6.12e-05 | 747 | 125 | 15 | int:SNW1 |
| Interaction | CTNNA1 interactions | 6.19e-05 | 347 | 125 | 10 | int:CTNNA1 | |
| Interaction | RHOB interactions | SPAG1 ABR ITGA6 MTMR1 BCR LANCL2 AKAP12 STK10 FAT1 STON2 PALM MACF1 CTNND1 RAB1A UTRN EPB41L2 | 6.41e-05 | 840 | 125 | 16 | int:RHOB |
| Interaction | SERBP1 interactions | DDX19B RAG1 FLNB ACAT2 KTN1 ACTG1 UFL1 EPB41L3 LANCL2 YARS1 AKAP12 HARS2 BRF1 LMNB1 AIFM1 TLN1 UBA6 RAB1A GCN1 EPB41 EPB41L2 CDK2 | 6.54e-05 | 1432 | 125 | 22 | int:SERBP1 |
| Interaction | RDX interactions | 7.09e-05 | 284 | 125 | 9 | int:RDX | |
| Interaction | RICTOR interactions | FLNB FLNC TRIM25 KTN1 ATG2B ACTG1 LMNB2 EPB41L3 LANCL2 AIFM1 TLN1 GCN1 UTRN EPB41 EPB41L2 | 7.32e-05 | 759 | 125 | 15 | int:RICTOR |
| Interaction | ABCE1 interactions | FLNB NUMA1 UFL1 LMNB2 ITPRID2 EPB41L3 LMNB1 AIFM1 MACF1 EPB41 EPB41L2 | 7.86e-05 | 431 | 125 | 11 | int:ABCE1 |
| Interaction | CDC5L interactions | DDX19B KRT18 CDKN2AIP ACTB UFL1 EPB41L3 MELK MECP2 RIF1 TLN1 ENAH MACF1 TLN2 CTNND1 GCN1 CDK2 | 7.88e-05 | 855 | 125 | 16 | int:CDC5L |
| Interaction | DRD3 interactions | 7.95e-05 | 37 | 125 | 4 | int:DRD3 | |
| Interaction | FNDC3A interactions | 8.11e-05 | 289 | 125 | 9 | int:FNDC3A | |
| Interaction | DOK2 interactions | 8.58e-05 | 116 | 125 | 6 | int:DOK2 | |
| Interaction | MOB3C interactions | TRIM25 CDKN2AIP KTN1 UFL1 HARS2 TLN1 STON2 CTNND1 GCN1 EPB41L2 | 9.20e-05 | 364 | 125 | 10 | int:MOB3C |
| Interaction | MARCKS interactions | ITGA6 MTMR1 EPB41L3 MECP2 LMNB1 PALM MACF1 CTNND1 RAB1A UTRN EPB41 EPB41L2 CDK2 | 9.35e-05 | 601 | 125 | 13 | int:MARCKS |
| Interaction | SP1 interactions | 9.41e-05 | 365 | 125 | 10 | int:SP1 | |
| Cytoband | 10q11.22 | 2.14e-04 | 41 | 129 | 3 | 10q11.22 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.40e-07 | 50 | 87 | 6 | 1293 | |
| GeneFamily | Erythrocyte membrane protein band 4.1|FERM domain containing | 4.29e-07 | 4 | 87 | 3 | 951 | |
| GeneFamily | Lamins | 6.85e-05 | 3 | 87 | 2 | 612 | |
| GeneFamily | PHD finger proteins | 7.32e-05 | 90 | 87 | 5 | 88 | |
| GeneFamily | Keratins, type I | 3.23e-04 | 28 | 87 | 3 | 608 | |
| GeneFamily | Actins | 3.39e-04 | 6 | 87 | 2 | 929 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 1.22e-03 | 11 | 87 | 2 | 1025 | |
| GeneFamily | Zinc fingers CXXC-type | 1.46e-03 | 12 | 87 | 2 | 136 | |
| GeneFamily | Annexins|Endogenous ligands | 1.72e-03 | 13 | 87 | 2 | 404 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 2.31e-03 | 15 | 87 | 2 | 903 | |
| GeneFamily | Cadherin related | 2.97e-03 | 17 | 87 | 2 | 24 | |
| GeneFamily | POU class homeoboxes and pseudogenes | 5.42e-03 | 23 | 87 | 2 | 523 | |
| Coexpression | TBK1.DF_DN | COL17A1 KTN1 RSF1 ATG2B MPDZ UFL1 DSN1 RIF1 LMNB1 TLN1 GOLGA4 | 1.69e-07 | 286 | 128 | 11 | M2864 |
| Coexpression | GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 6.38e-07 | 200 | 128 | 9 | M304 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TPST1 FLNB KDM5A ITGA6 MELK MECP2 STK10 MALT1 RIF1 FAT1 UTP18 LMNB1 ATAD2B MACF1 DENND5A PIBF1 GOLGA4 | 9.65e-07 | 856 | 128 | 17 | M4500 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.00e-06 | 180 | 128 | 8 | M8239 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP | FLNC SPAG1 KTN1 NUMA1 ITGA6 CHD2 ITPRID2 MALT1 ENAH PIBF1 GOLGA4 | 3.45e-06 | 389 | 128 | 11 | M6520 |
| Coexpression | EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP | 6.53e-06 | 200 | 128 | 8 | M78 | |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP | 6.53e-06 | 200 | 128 | 8 | M6649 | |
| Coexpression | TRAVAGLINI_LUNG_LYMPHATIC_CELL | 9.01e-06 | 209 | 128 | 8 | M41670 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | FLNB EOGT CCDC186 ITGA6 ITPRID2 PALMD AKAP12 GIPC3 ABCB1 MALT1 TLN1 PZP UTRN CDH5 TPD52L1 | 2.97e-05 | 888 | 128 | 15 | M39049 |
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_UP | SPAG1 CCPG1 EOGT OLFML2B ATG2B HMGCS2 ENAH TLN2 CTNND1 RAB1A UTRN EPB41L2 | 2.99e-05 | 583 | 128 | 12 | M17454 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | ACAT2 CDKN2AIP LMNB2 ANKRD36C BCR RUFY1 MELK DSN1 YARS1 ANKRD36B RIF1 UTP18 BRF1 LMNB1 AIFM1 HEBP1 MTMR2 EPB41L2 CDK2 | 3.50e-05 | 1363 | 128 | 19 | M45782 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | DDX19B SUPT20HL1 TRAF6 ACTB SUPT20HL2 LMNB2 FANCM LANCL2 AKAP12 HIVEP3 MTMR2 ACIN1 EPB41L2 CDK2 | 3.50e-05 | 794 | 128 | 14 | MM982 |
| Coexpression | GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_DN | 5.01e-05 | 195 | 128 | 7 | M9804 | |
| Coexpression | GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN | 5.70e-05 | 199 | 128 | 7 | M7659 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 5.70e-05 | 199 | 128 | 7 | M5893 | |
| Coexpression | GSE3982_MAST_CELL_VS_BASOPHIL_DN | 5.70e-05 | 199 | 128 | 7 | M5439 | |
| Coexpression | GSE3982_MAST_CELL_VS_TH1_UP | 5.70e-05 | 199 | 128 | 7 | M5453 | |
| Coexpression | ULE_SPLICING_VIA_NOVA2 | 5.78e-05 | 43 | 128 | 4 | M1551 | |
| Coexpression | ULE_SPLICING_VIA_NOVA2 | 5.78e-05 | 43 | 128 | 4 | MM666 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_24H_BMDC_DN | 5.88e-05 | 200 | 128 | 7 | M3725 | |
| Coexpression | SASSON_RESPONSE_TO_FORSKOLIN_DN | 6.16e-05 | 85 | 128 | 5 | M12924 | |
| Coexpression | SASSON_RESPONSE_TO_GONADOTROPHINS_DN | 6.52e-05 | 86 | 128 | 5 | M17143 | |
| Coexpression | FAN_OVARY_CL11_MURAL_GRANULOSA_CELL | 6.74e-05 | 444 | 128 | 10 | M41713 | |
| Coexpression | WOOD_EBV_EBNA1_TARGETS_DN | 8.94e-05 | 48 | 128 | 4 | M19460 | |
| Coexpression | YAGI_AML_WITH_T_8_21_TRANSLOCATION | 9.17e-05 | 372 | 128 | 9 | M19261 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN | FLNC ACTG1 ITPRID2 IKBIP AKAP12 STK10 MALT1 MTMR2 DENND5A EPB41L2 | 9.86e-05 | 465 | 128 | 10 | M9192 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | FLNB KDM5A MELK MECP2 FAT1 UTP18 ATAD2B DENND5A PIBF1 GOLGA4 | 1.00e-04 | 466 | 128 | 10 | M13522 |
| Coexpression | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23 | 1.04e-04 | 19 | 128 | 3 | M13194 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | GGA2 KDM5A RBM33 KTN1 ACTB RSF1 NUMA1 CHD2 MECP2 ABCB1 HIVEP3 STK10 MALT1 RIF1 TLN1 CD47 KMT2A MACF1 UTRN | 1.16e-04 | 1492 | 128 | 19 | M40023 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_2_CELL | 1.17e-04 | 300 | 128 | 8 | M45675 | |
| Coexpression | LIU_SOX4_TARGETS_DN | 1.47e-04 | 310 | 128 | 8 | M17287 | |
| Coexpression | GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 1.99e-04 | 171 | 128 | 6 | M9092 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | ACAT2 KIAA0586 ITGA6 LMNB2 ITPRID2 ANKRD36C MELK DSN1 ZFAND4 ANKRD36B RIF1 LMNB1 EPB41L2 CDK2 | 2.05e-04 | 939 | 128 | 14 | M45768 |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | TRIM25 COL17A1 ABR ANXA8 BCR YARS1 STK10 MALT1 FAT1 AIFM1 TLN1 ENAH STON2 | 2.53e-04 | 843 | 128 | 13 | M2356 |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 2.54e-04 | 179 | 128 | 6 | M39308 | |
| Coexpression | MARKEY_RB1_CHRONIC_LOF_UP | 2.67e-04 | 116 | 128 | 5 | MM1090 | |
| Coexpression | MTOR_UP.N4.V1_DN | 2.95e-04 | 184 | 128 | 6 | M2756 | |
| Coexpression | AIZARANI_LIVER_C39_EPCAM_POS_BILE_DUCT_CELLS_4 | 2.95e-04 | 184 | 128 | 6 | M39135 | |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_DN | 2.97e-04 | 260 | 128 | 7 | M41075 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | 3.20e-04 | 440 | 128 | 9 | M39039 | |
| Coexpression | FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL | KRT18 KDM5A CDKN2AIP KTN1 ACTB ITGA6 ACTG1 CD47 MTMR2 ACIN1 CTNND1 | 3.28e-04 | 644 | 128 | 11 | M41717 |
| Coexpression | CHEN_LUNG_CANCER_SURVIVAL | 3.41e-04 | 28 | 128 | 3 | M8526 | |
| Coexpression | GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_DN | 3.50e-04 | 190 | 128 | 6 | M6589 | |
| Coexpression | TOOKER_GEMCITABINE_RESISTANCE_DN | 3.50e-04 | 123 | 128 | 5 | M18806 | |
| Coexpression | GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_UP | 3.80e-04 | 193 | 128 | 6 | M4654 | |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_UP | 3.80e-04 | 193 | 128 | 6 | M6730 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN | DDX19B ITGA6 MPDZ UFL1 EPB41L3 ABCB1 FAT1 AIFM1 RAB1A GOLGA4 | 3.95e-04 | 553 | 128 | 10 | M1475 |
| Coexpression | GSE20727_CTRL_VS_H2O2_TREATED_DC_DN | 4.12e-04 | 196 | 128 | 6 | M9243 | |
| Coexpression | ERBB2_UP.V1_DN | 4.24e-04 | 197 | 128 | 6 | M2635 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | DDX19B TRAF6 ACTB LMNB2 FANCM LANCL2 AKAP12 HIVEP3 MTMR2 ACIN1 EPB41L2 CDK2 | 4.30e-04 | 776 | 128 | 12 | M1107 |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_DN | 4.35e-04 | 198 | 128 | 6 | M4554 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | 4.35e-04 | 198 | 128 | 6 | M4451 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | TPST1 ACTB ACTG1 BCR RUFY1 DSN1 SH3D21 IKBIP ABCB1 LMNB1 AIFM1 TLN1 TLN2 CTNND2 TPD52L1 | 4.42e-04 | 1136 | 128 | 15 | M2247 |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_DN | 4.47e-04 | 199 | 128 | 6 | M8029 | |
| Coexpression | GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN | 4.47e-04 | 199 | 128 | 6 | M8352 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 4.47e-04 | 199 | 128 | 6 | M7254 | |
| Coexpression | GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_UP | 4.47e-04 | 199 | 128 | 6 | M8580 | |
| Coexpression | GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP | 4.59e-04 | 200 | 128 | 6 | M9467 | |
| Coexpression | GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_DN | 4.59e-04 | 200 | 128 | 6 | M3260 | |
| Coexpression | GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN | 4.59e-04 | 200 | 128 | 6 | M9848 | |
| Coexpression | GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN | 4.59e-04 | 200 | 128 | 6 | M5081 | |
| Coexpression | GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_DN | 4.59e-04 | 200 | 128 | 6 | M5099 | |
| Coexpression | GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP | 4.59e-04 | 200 | 128 | 6 | M7789 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_UP | 4.59e-04 | 200 | 128 | 6 | M4026 | |
| Coexpression | HALLMARK_APICAL_JUNCTION | 4.59e-04 | 200 | 128 | 6 | M5915 | |
| Coexpression | GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP | 4.59e-04 | 200 | 128 | 6 | M6537 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH2_UP | 4.59e-04 | 200 | 128 | 6 | M5566 | |
| Coexpression | GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 4.59e-04 | 200 | 128 | 6 | M9164 | |
| Coexpression | KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_UP | 4.59e-04 | 200 | 128 | 6 | M3030 | |
| Coexpression | GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_DN | 4.59e-04 | 200 | 128 | 6 | M6954 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | RAD51B FLNC ITGA6 POU3F4 EPB41L3 RIF1 BRF1 UBA6 TLN2 IFT122 CTNND2 KIF25 TPD52L1 | 5.17e-04 | 909 | 128 | 13 | M41018 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | FLNC SPAG1 ITGA6 MPDZ ITPRID2 EPB41L3 LANCL2 FAT1 CD47 SPAG17 | 5.28e-04 | 574 | 128 | 10 | M39056 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_DN | 5.50e-04 | 207 | 128 | 6 | MM988 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 5.59e-04 | 289 | 128 | 7 | M2196 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | FLNB KTN1 ITGA6 MPDZ ITPRID2 PALMD KMT2A MACF1 CTNND1 UTRN CDH5 | 1.71e-11 | 200 | 129 | 11 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.32e-09 | 200 | 129 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.32e-09 | 200 | 129 | 9 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-08 | 184 | 129 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.23e-07 | 199 | 129 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.28e-07 | 200 | 129 | 8 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.28e-07 | 200 | 129 | 8 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.28e-07 | 200 | 129 | 8 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.28e-07 | 200 | 129 | 8 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.28e-07 | 200 | 129 | 8 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.97e-07 | 178 | 129 | 7 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.16e-06 | 185 | 129 | 7 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-06 | 186 | 129 | 7 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 193 | 129 | 7 | e4b440d50ae7391b26924778be6d9d53e0692449 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 193 | 129 | 7 | e523dc5751f6fdcd4fc1a62b1eecd43f6ae79da9 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-06 | 193 | 129 | 7 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-06 | 193 | 129 | 7 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 193 | 129 | 7 | 1772f2ac217727de63c4a9303881b3a19a6bb0f0 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-06 | 194 | 129 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-06 | 197 | 129 | 7 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.77e-06 | 197 | 129 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-06 | 197 | 129 | 7 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-06 | 197 | 129 | 7 | dcabea5c50c133c9a4e294e447462d0393174ea7 | |
| ToppCell | LAM-Endothelial-LymEndo|Endothelial / Condition, Lineage and Cell class | 1.83e-06 | 198 | 129 | 7 | ba64b1c95dfaa995045239d412e725596f6c482e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-06 | 198 | 129 | 7 | e06d41a7254a09e037ec404be2d8c352d5cbd7f4 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-06 | 198 | 129 | 7 | 5d42f4fda2081ea3e9f62a00e7eea702e0d0be7d | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Lymphatic|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.83e-06 | 198 | 129 | 7 | 7a99c341736a4a2ac48ef8e2f7951f21a7378946 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-06 | 198 | 129 | 7 | ceede961ad9af6a3159db7efaa5087bf38aafc2d | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.89e-06 | 199 | 129 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.89e-06 | 199 | 129 | 7 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.95e-06 | 200 | 129 | 7 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.95e-06 | 200 | 129 | 7 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 5.24e-06 | 151 | 129 | 6 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 7.84e-06 | 162 | 129 | 6 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.65e-06 | 168 | 129 | 6 | a74c8a9e3299183fba31ce3053ef325b5dbcd104 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.65e-06 | 168 | 129 | 6 | dae37b316ce80dfe4236c4ed7f0d4e7c340fa7b6 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-05 | 173 | 129 | 6 | 7dc988fc0ba29990567bf1bcdeb3faeeee507eb1 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 176 | 129 | 6 | 29cda51a99100ddd2928cadc92da40f001d7e1f4 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 176 | 129 | 6 | 01774a86d7d92f31a056b753f9844f923038003e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 178 | 129 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-05 | 179 | 129 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 179 | 129 | 6 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-05 | 181 | 129 | 6 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-05 | 183 | 129 | 6 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-05 | 183 | 129 | 6 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 1.57e-05 | 183 | 129 | 6 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.57e-05 | 183 | 129 | 6 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | facs-Heart-LA-24m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 186 | 129 | 6 | f8ed078684ce6d914fd9cb1f0ef4aba36db39b3f | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-05 | 186 | 129 | 6 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | facs-Heart-LA-24m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 186 | 129 | 6 | 1d08e60d239153c9e5ea42135d702d494d8b42b1 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-05 | 186 | 129 | 6 | 7a8da2ad140bea3207bd868212cc5e201d586772 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-05 | 186 | 129 | 6 | dc394034929c6b10ae0e1c1a028cc3d4ce873298 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 187 | 129 | 6 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | ASK428-Endothelial-Lymphatic|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.83e-05 | 188 | 129 | 6 | c371bc340966cfe9205cbf4b62c6452f49f2559f | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-05 | 189 | 129 | 6 | 9da012fdfa9a8d488cab710a463a1d70e89f990c | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-05 | 190 | 129 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | facs-Skin|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-05 | 191 | 129 | 6 | ae524103331fa53fa82888dbb567fc36abcee7e0 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.00e-05 | 191 | 129 | 6 | 3307dbccadb09c62b0e1c0235ec89bb294d748c3 | |
| ToppCell | Control-Lymphoid_T/NK-NK_CD56bright|Control / Disease group, lineage and cell class | 2.00e-05 | 191 | 129 | 6 | e842f29bc03ed6734b2a7b975e7830a498f2743c | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.06e-05 | 192 | 129 | 6 | 30cefa0990ba1f379f350bfbf994a78db145075e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-05 | 192 | 129 | 6 | 9d53b42cdb537b30233cdfdc08052c8b13a1113f | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.06e-05 | 192 | 129 | 6 | b877d14be9d04ab0010e340909e3a23de92613db | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-05 | 192 | 129 | 6 | b016e229300c183e14c0e2bba494bf49c7899112 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-05 | 192 | 129 | 6 | ac96831492c62ad9e1f7d0b764fbdf7d8a189ad9 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.06e-05 | 192 | 129 | 6 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-05 | 192 | 129 | 6 | 042391162df2e3d0027688dd14163c4c6821afe0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.06e-05 | 192 | 129 | 6 | bd3fa6c8fcb618db64d11f25cabaf08608957c35 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-05 | 192 | 129 | 6 | 9ae05db5bfb8b9d3935c0328e6f2d489d2b1ebfd | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-05 | 192 | 129 | 6 | 71b0bfee0461ff64cef35881db3959c517e9731b | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 2.06e-05 | 192 | 129 | 6 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-05 | 192 | 129 | 6 | 2510f22197502f60fd266b7f42eff040f25b8ae7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-05 | 192 | 129 | 6 | a116db7dec495e5a0ba9c7537057cd1e567d7885 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-05 | 192 | 129 | 6 | e8e316f396834bcd34843e56e1d86f310fd6aada | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-05 | 192 | 129 | 6 | 66defad13bd8e79319741e43ddb056841710b1d7 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-05 | 193 | 129 | 6 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-05 | 193 | 129 | 6 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-05 | 193 | 129 | 6 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 194 | 129 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.18e-05 | 194 | 129 | 6 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.18e-05 | 194 | 129 | 6 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 194 | 129 | 6 | 37803f4abf1aa1ad771c9cd293933003d7101e70 | |
| ToppCell | ASK440-Endothelial-Lymphatic|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.18e-05 | 194 | 129 | 6 | 4aa68e39e36094359dfbedf1e9bdf3ea5c32ed1a | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.24e-05 | 195 | 129 | 6 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.24e-05 | 195 | 129 | 6 | fc75f04eb475c8139cc5c35e6be22e73fb2be9e6 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.24e-05 | 195 | 129 | 6 | 83d45ff5e5bc704448431149fffb2e4c1278f279 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 2.31e-05 | 196 | 129 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | Control-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 2.31e-05 | 196 | 129 | 6 | e0cf617b0f5d9c3c19574f587a3d0ccbf93d8ca4 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 2.31e-05 | 196 | 129 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.38e-05 | 197 | 129 | 6 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | Bronchial_Brush-Epithelial|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.38e-05 | 197 | 129 | 6 | 272c7f4e582ef57564450540242b0db766b78328 | |
| ToppCell | normal_Lung-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 2.38e-05 | 197 | 129 | 6 | c838d0f64e3b43a616a9e381b8139bfe9aa32da7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.38e-05 | 197 | 129 | 6 | 9e948b2e0f7e426f1e6f95bbbf4282fbddc2b99d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-05 | 197 | 129 | 6 | 2430f31d9312338e0ca23bfc6bdb0365340860fd | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.38e-05 | 197 | 129 | 6 | 5a63c2b824c7d0dbbc706e408459c9b9fe65daaa | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor-AT1_Progenitor|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.38e-05 | 197 | 129 | 6 | d66f3f7fb9a2944de509e3728e49bc7f2d2575af | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.44e-05 | 198 | 129 | 6 | 77517df37dc894c78ef1e2b24dd7ba31f928bdb7 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.44e-05 | 198 | 129 | 6 | 9ab0db78394e730f6866b2db80047149024ad5f6 | |
| ToppCell | 3'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-05 | 198 | 129 | 6 | 7ad7726fc405806b1d7824f58548073ea5e0c70b | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-05 | 198 | 129 | 6 | 1fbec311f2c987ca90a023a5989128c05aa12d5c | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-05 | 198 | 129 | 6 | 4f26a60e99f42343e5af7221723e108a1a1b7827 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.97e-05 | 49 | 89 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.49e-05 | 50 | 89 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.49e-05 | 50 | 89 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Drug | plakin | 3.43e-07 | 82 | 125 | 7 | CID000018752 | |
| Drug | Triflupromazine hydrochloride [1098-60-8]; Up 200; 10.2uM; PC3; HT_HG-U133A | 1.13e-06 | 191 | 125 | 9 | 1813_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.23e-06 | 193 | 125 | 9 | 6967_DN | |
| Drug | Ioversol [87771-40-2]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.40e-06 | 196 | 125 | 9 | 5326_DN | |
| Drug | Protoveratrine A [143-57-7]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.46e-06 | 197 | 125 | 9 | 4963_DN | |
| Drug | Diflunisal [22494-42-4]; Up 200; 16uM; MCF7; HT_HG-U133A | 1.52e-06 | 198 | 125 | 9 | 1490_UP | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; PC3; HT_HG-U133A | 1.59e-06 | 199 | 125 | 9 | 5096_DN | |
| Drug | nocodazole | TPST1 KRT18 ACTB NUMA1 ACTG1 LMNB2 DSN1 AKAP12 LMNB1 CTNND1 RAB1A GOLGA4 CDK2 | 2.31e-06 | 477 | 125 | 13 | CID000004122 |
| Drug | Fluorouracil | KRT18 KDM5A CCDC186 CDKN2AIP ACTB EPB41L3 MELK IKBIP YARS1 AKAP12 ABCB1 ANKRD36B MALT1 LMNB1 ZNF532 AIFM1 ENAH MACF1 CTNND2 USH2A CDH5 CDK2 | 4.76e-06 | 1364 | 125 | 22 | ctd:D005472 |
| Drug | Betamethasone [378-44-9]; Up 200; 10.2uM; HL60; HG-U133A | 7.89e-06 | 183 | 125 | 8 | 1590_UP | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.16e-05 | 193 | 125 | 8 | 6205_DN | |
| Drug | Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.16e-05 | 193 | 125 | 8 | 4846_DN | |
| Drug | Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; HL60; HT_HG-U133A | 1.16e-05 | 193 | 125 | 8 | 1268_DN | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; PC3; HT_HG-U133A | 1.16e-05 | 193 | 125 | 8 | 6751_DN | |
| Drug | NSC34533 | 1.17e-05 | 54 | 125 | 5 | CID000003512 | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | 1.21e-05 | 194 | 125 | 8 | 1670_DN | |
| Drug | Dapsone [80-08-0]; Up 200; 16.2uM; PC3; HT_HG-U133A | 1.21e-05 | 194 | 125 | 8 | 1827_UP | |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.21e-05 | 194 | 125 | 8 | 4341_DN | |
| Drug | Felodipine [72509-76-3]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.21e-05 | 194 | 125 | 8 | 6695_DN | |
| Drug | Fosfosal [6064-83-1]; Down 200; 18.4uM; PC3; HT_HG-U133A | 1.21e-05 | 194 | 125 | 8 | 4239_DN | |
| Drug | Phthalylsulfathiazole [85-73-4]; Down 200; 10uM; PC3; HT_HG-U133A | 1.25e-05 | 195 | 125 | 8 | 4653_DN | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.25e-05 | 195 | 125 | 8 | 5004_DN | |
| Drug | Asiaticoside [16830-15-2]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 1.25e-05 | 195 | 125 | 8 | 7004_DN | |
| Drug | SB 202190; Down 200; 1uM; MCF7; HT_HG-U133A | 1.25e-05 | 195 | 125 | 8 | 7054_DN | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; PC3; HT_HG-U133A | 1.30e-05 | 196 | 125 | 8 | 6760_DN | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A | 1.30e-05 | 196 | 125 | 8 | 3724_DN | |
| Drug | Sulfadiazine [68-35-9]; Up 200; 16uM; PC3; HT_HG-U133A | 1.30e-05 | 196 | 125 | 8 | 1810_UP | |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.35e-05 | 197 | 125 | 8 | 5479_DN | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.35e-05 | 197 | 125 | 8 | 2641_UP | |
| Drug | Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.35e-05 | 197 | 125 | 8 | 6758_DN | |
| Drug | 5-IAF | 3.15e-05 | 66 | 125 | 5 | CID000123822 | |
| Drug | ON 01910 | 3.20e-05 | 162 | 125 | 7 | ctd:C507134 | |
| Drug | methyl 9-octadecenoate | 3.61e-05 | 112 | 125 | 6 | CID000008202 | |
| Drug | 1y6r | 3.97e-05 | 35 | 125 | 4 | CID000446609 | |
| Drug | AC1L1DW2 | 7.68e-05 | 186 | 125 | 7 | CID000002532 | |
| Drug | kavain | 8.94e-05 | 3 | 125 | 2 | ctd:C011889 | |
| Drug | Oxamniquine [21738-42-1]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 9.07e-05 | 191 | 125 | 7 | 4124_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 9.07e-05 | 191 | 125 | 7 | 4269_DN | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; PC3; HT_HG-U133A | 9.07e-05 | 191 | 125 | 7 | 6710_DN | |
| Drug | Hesperidin [520-26-3]; Down 200; 6.6uM; PC3; HT_HG-U133A | 9.37e-05 | 192 | 125 | 7 | 6714_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A | 9.37e-05 | 192 | 125 | 7 | 1647_DN | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A | 9.68e-05 | 193 | 125 | 7 | 5232_DN | |
| Drug | Methylergometrine maleate [113-42-8]; Down 200; 8.8uM; PC3; HT_HG-U133A | 9.68e-05 | 193 | 125 | 7 | 6704_DN | |
| Drug | Lidocaone hydrochloride [73-78-9]; Down 200; 14.8uM; PC3; HT_HG-U133A | 9.68e-05 | 193 | 125 | 7 | 4596_DN | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 9.68e-05 | 193 | 125 | 7 | 3624_DN | |
| Drug | Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 9.68e-05 | 193 | 125 | 7 | 7447_DN | |
| Drug | A805480 | 9.92e-05 | 44 | 125 | 4 | CID000620368 | |
| Drug | Betazole hydrochloride; Up 200; 27uM; PC3; HT_HG-U133A | 1.00e-04 | 194 | 125 | 7 | 1812_UP | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 1.00e-04 | 194 | 125 | 7 | 7538_DN | |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.00e-04 | 194 | 125 | 7 | 2293_DN | |
| Drug | Gly-His-Lys acetate salt; Down 200; 1uM; MCF7; HT_HG-U133A | 1.00e-04 | 194 | 125 | 7 | 6575_DN | |
| Drug | Roxithromycin [80214-83-1]; Down 200; 4.8uM; PC3; HT_HG-U133A | 1.00e-04 | 194 | 125 | 7 | 4192_DN | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | 1.00e-04 | 194 | 125 | 7 | 4001_DN | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 1.03e-04 | 195 | 125 | 7 | 4994_DN | |
| Drug | estradiol, USP; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.03e-04 | 195 | 125 | 7 | 2668_UP | |
| Drug | Flufenamic acid [530-78-9]; Up 200; 14.2uM; PC3; HT_HG-U133A | 1.03e-04 | 195 | 125 | 7 | 2104_UP | |
| Drug | Ramipril [87333-19-5]; Up 200; 9.6uM; PC3; HT_HG-U133A | 1.03e-04 | 195 | 125 | 7 | 7144_UP | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; HL60; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 2511_DN | |
| Drug | Benzonatate [104-31-4]; Up 200; 6.6uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 1801_UP | |
| Drug | Fluticasone propionate [80474-14-2]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 7348_DN | |
| Drug | Ethoxyquin [91-53-2]; Up 200; 18.4uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 4321_UP | |
| Drug | Primidone [125-33-7]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 5323_UP | |
| Drug | Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 7357_DN | |
| Drug | Retinoic acid [302-79-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 5767_DN | |
| Drug | Riboflavine [83-88-5]; Down 200; 10.6uM; HL60; HG-U133A | 1.07e-04 | 196 | 125 | 7 | 1767_DN | |
| Drug | Chrysin [480-40-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 5505_DN | |
| Drug | Midecamycin [35457-80-8]; Down 200; 5uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 6745_DN | |
| Drug | Austricine [10180-88-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 2812_DN | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Up 200; 10uM; PC3; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 6335_UP | |
| Drug | Heptaminol hydrochloride [543-15-7]; Up 200; 22uM; PC3; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 1825_UP | |
| Drug | Etofylline [519-37-9]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 5467_UP | |
| Drug | CP-863187 [668981-07-5]; Down 200; 10uM; PC3; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 7512_DN | |
| Drug | Tenoxicam [59804-37-4]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 4102_DN | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Down 200; 0.1uM; MCF7; HG-U133A | 1.10e-04 | 197 | 125 | 7 | 3_DN | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 7201_DN | |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Down 200; 21uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 3338_DN | |
| Drug | Viomycin sulfate [37883-00-4]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 7036_UP | |
| Drug | Tyloxapol [25301-02-4]; Down 200; 4uM; MCF7; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 6452_DN | |
| Drug | Mebendazole [31431-39-7]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 4694_DN | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; HL60; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 2194_DN | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 1806_UP | |
| Drug | Estropipate [7280-37-7]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 4472_UP | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HG-U133A | 1.14e-04 | 198 | 125 | 7 | 426_DN | |
| Drug | W-13, hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 1.14e-04 | 198 | 125 | 7 | 440_DN | |
| Drug | Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.17e-04 | 199 | 125 | 7 | 7192_DN | |
| Drug | Antimycin A [1397-94-0]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 1.17e-04 | 199 | 125 | 7 | 5472_DN | |
| Drug | estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.17e-04 | 199 | 125 | 7 | 6968_DN | |
| Drug | nifedipine; Down 200; 10uM; MCF7; HG-U133A | 1.17e-04 | 199 | 125 | 7 | 603_DN | |
| Drug | Dipyrone [5907-38-0]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.17e-04 | 199 | 125 | 7 | 3835_UP | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.17e-04 | 199 | 125 | 7 | 5309_DN | |
| Drug | Hexetidine [141-94-6]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.17e-04 | 199 | 125 | 7 | 6319_DN | |
| Drug | Tobramycin [32986-56-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.17e-04 | 199 | 125 | 7 | 2841_DN | |
| Drug | Neomycin sulfate [1405-10-3]; Up 200; 4.2uM; HL60; HG-U133A | 1.17e-04 | 199 | 125 | 7 | 1383_UP | |
| Drug | Iodipamide [606-17-7]; Down 200; 3.6uM; MCF7; HT_HG-U133A | 1.21e-04 | 200 | 125 | 7 | 5510_DN | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.21e-04 | 200 | 125 | 7 | 5299_DN | |
| Drug | Canavanine sulfate monohydrate (L,+) [206996-57-8]; Up 200; 13.6uM; HL60; HT_HG-U133A | 1.21e-04 | 200 | 125 | 7 | 2141_UP | |
| Drug | Isoxicam [34552-84-6]; Down 200; 12uM; PC3; HT_HG-U133A | 1.21e-04 | 200 | 125 | 7 | 7268_DN | |
| Drug | Y 290 | 1.24e-04 | 18 | 125 | 3 | CID000114729 | |
| Drug | 12 p | 1.39e-04 | 274 | 125 | 8 | CID000081248 | |
| Drug | tolytoxin | 1.47e-04 | 19 | 125 | 3 | CID006440827 | |
| Disease | myopathy (implicated_via_orthology) | 1.47e-09 | 48 | 127 | 7 | DOID:423 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | FLNC ELOA2 LMNB2 AKAP12 ABCB1 HIVEP3 FAT1 BRF1 ACIN1 CTNND2 SPAG17 PZP CDH5 | 1.11e-05 | 702 | 127 | 13 | C0009402 |
| Disease | Baraitser-Winter syndrome | 1.84e-05 | 2 | 127 | 2 | cv:C1853623 | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 1.84e-05 | 2 | 127 | 2 | C1855722 | |
| Disease | Fryns-Aftimos Syndrome | 1.84e-05 | 2 | 127 | 2 | C1853623 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 5.50e-05 | 3 | 127 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 5.50e-05 | 3 | 127 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | autosomal recessive Emery-Dreifuss muscular dystrophy 3 (implicated_via_orthology) | 5.50e-05 | 3 | 127 | 2 | DOID:0070248 (implicated_via_orthology) | |
| Disease | congenital muscular dystrophy due to LMNA mutation (implicated_via_orthology) | 5.50e-05 | 3 | 127 | 2 | DOID:0110640 (implicated_via_orthology) | |
| Disease | familial partial lipodystrophy type 2 (implicated_via_orthology) | 5.50e-05 | 3 | 127 | 2 | DOID:0070202 (implicated_via_orthology) | |
| Disease | autosomal dominant Emery-Dreifuss muscular dystrophy 2 (implicated_via_orthology) | 5.50e-05 | 3 | 127 | 2 | DOID:0070247 (implicated_via_orthology) | |
| Disease | muscular dystrophy (implicated_via_orthology) | 9.79e-05 | 21 | 127 | 3 | DOID:9884 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1A (implicated_via_orthology) | 1.10e-04 | 4 | 127 | 2 | DOID:0110425 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 1.48e-04 | 24 | 127 | 3 | DOID:10595 (implicated_via_orthology) | |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 1.67e-04 | 25 | 127 | 3 | DOID:0050589 (implicated_via_orthology) | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 2.73e-04 | 6 | 127 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 3.81e-04 | 7 | 127 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | Uveoretinal Coloboma | 3.81e-04 | 7 | 127 | 2 | C4554007 | |
| Disease | colorectal adenocarcinoma (is_implicated_in) | 4.61e-04 | 35 | 127 | 3 | DOID:0050861 (is_implicated_in) | |
| Disease | exudative vitreoretinopathy (implicated_via_orthology) | 5.06e-04 | 8 | 127 | 2 | DOID:0050535 (implicated_via_orthology) | |
| Disease | Moyamoya disease (implicated_via_orthology) | 5.06e-04 | 8 | 127 | 2 | DOID:13099 (implicated_via_orthology) | |
| Disease | triacylglycerol 58:6 measurement | 5.06e-04 | 8 | 127 | 2 | EFO_0010440 | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 5.06e-04 | 8 | 127 | 2 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 5.06e-04 | 8 | 127 | 2 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 5.06e-04 | 8 | 127 | 2 | DOID:14004 (implicated_via_orthology) | |
| Disease | progeria (implicated_via_orthology) | 5.06e-04 | 8 | 127 | 2 | DOID:3911 (implicated_via_orthology) | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 6.49e-04 | 9 | 127 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | Congenital ocular coloboma (disorder) | 6.49e-04 | 9 | 127 | 2 | C0009363 | |
| Disease | Neurodevelopmental Disorders | 7.11e-04 | 93 | 127 | 4 | C1535926 | |
| Disease | Malignant neoplasm of breast | RAD51B FLNB KRT18 KTN1 FRMPD1 EPB41L3 RUFY1 AKAP12 ABCB1 RIF1 ZNF532 MACF1 CDH5 | 7.55e-04 | 1074 | 127 | 13 | C0006142 |
| Disease | Charcot-Marie-Tooth disease | 7.91e-04 | 42 | 127 | 3 | cv:C0007959 | |
| Disease | intestinal atresia (implicated_via_orthology) | 8.09e-04 | 10 | 127 | 2 | DOID:10486 (implicated_via_orthology) | |
| Disease | Congenital neurologic anomalies | 8.09e-04 | 10 | 127 | 2 | C0497552 | |
| Disease | Cranioschisis | 8.09e-04 | 10 | 127 | 2 | C0265541 | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 8.09e-04 | 10 | 127 | 2 | DOID:13832 (implicated_via_orthology) | |
| Disease | hearing impairment | 8.65e-04 | 98 | 127 | 4 | C1384666 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.18e-03 | 12 | 127 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Myeloproliferative disease | 1.18e-03 | 12 | 127 | 2 | C0027022 | |
| Disease | Epilepsy | 1.28e-03 | 109 | 127 | 4 | C0014544 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 1.32e-03 | 50 | 127 | 3 | C0023453 | |
| Disease | Myopia | 1.43e-03 | 385 | 127 | 7 | HP_0000545 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 1.48e-03 | 52 | 127 | 3 | C0023452 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 1.62e-03 | 14 | 127 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | Liver carcinoma | 1.62e-03 | 507 | 127 | 8 | C2239176 | |
| Disease | gout | 1.62e-03 | 196 | 127 | 5 | EFO_0004274 | |
| Disease | Diffuse Large B-Cell Lymphoma | 1.73e-03 | 55 | 127 | 3 | C0079744 | |
| Disease | Necrosis | 1.73e-03 | 55 | 127 | 3 | C0027540 | |
| Disease | Liver Cirrhosis, Experimental | 1.94e-03 | 774 | 127 | 10 | C0023893 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 2.12e-03 | 16 | 127 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | Post-Traumatic Osteoporosis | 2.34e-03 | 61 | 127 | 3 | C0751406 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 2.34e-03 | 61 | 127 | 3 | C1961102 | |
| Disease | Osteoporosis, Senile | 2.34e-03 | 61 | 127 | 3 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 2.34e-03 | 61 | 127 | 3 | C0001787 | |
| Disease | uridine diphosphate galactose measurement, uridine diphosphate glucose measurement | 2.40e-03 | 17 | 127 | 2 | EFO_0010543, EFO_0010544 | |
| Disease | Dystonia, Limb | 2.40e-03 | 17 | 127 | 2 | C0751093 | |
| Disease | Dystonia, Diurnal | 2.40e-03 | 17 | 127 | 2 | C0393610 | |
| Disease | non-Hodgkin lymphoma (is_implicated_in) | 2.40e-03 | 17 | 127 | 2 | DOID:0060060 (is_implicated_in) | |
| Disease | Familial Progressive Myoclonic Epilepsy | 2.40e-03 | 17 | 127 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 2.40e-03 | 17 | 127 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 2.40e-03 | 17 | 127 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 2.40e-03 | 17 | 127 | 2 | C0751780 | |
| Disease | May-White Syndrome | 2.40e-03 | 17 | 127 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 2.40e-03 | 17 | 127 | 2 | C0751781 | |
| Disease | HETE measurement | 2.45e-03 | 62 | 127 | 3 | EFO_0801166 | |
| Disease | Osteoporosis | 2.56e-03 | 63 | 127 | 3 | C0029456 | |
| Disease | Dystonia, Paroxysmal | 2.69e-03 | 18 | 127 | 2 | C0393588 | |
| Disease | Adrenocortical carcinoma | 2.69e-03 | 18 | 127 | 2 | C0206686 | |
| Disease | Myeloid Leukemia | 2.69e-03 | 18 | 127 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 2.69e-03 | 18 | 127 | 2 | C0023466 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 2.69e-03 | 18 | 127 | 2 | C0751779 | |
| Disease | mean corpuscular hemoglobin concentration | RAD51B ACTB RIF1 BRF1 HEBP1 ATAD2B MTMR2 LRP5 MACF1 PIBF1 EPB41 EPB41L2 | 2.97e-03 | 1105 | 127 | 12 | EFO_0004528 |
| Disease | sexual dimorphism measurement | RAD51B FAM184B KMT2B ERVW-1 DSN1 STK10 NPIPB8 NPIPB6 ATAD2B MACF1 GCN1 EPB41L2 | 2.99e-03 | 1106 | 127 | 12 | EFO_0021796 |
| Disease | Precursor B-cell lymphoblastic leukemia | 3.66e-03 | 21 | 127 | 2 | C1292769 | |
| Disease | Joubert syndrome 1 | 3.66e-03 | 21 | 127 | 2 | C4551568 | |
| Disease | chronic myeloid leukemia (is_implicated_in) | 3.66e-03 | 21 | 127 | 2 | DOID:8552 (is_implicated_in) | |
| Disease | nucleus accumbens volume | 4.01e-03 | 22 | 127 | 2 | EFO_0006931 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.28e-03 | 152 | 127 | 4 | DOID:0060041 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RSSKEKIRLDEAGVT | 116 | O60507 | |
| GVKISVVTKRERSKV | 646 | Q12979 | |
| HEVKKVTLGDTLTRR | 966 | Q9UKV3 | |
| KNKRDGTEVTERIVT | 6 | Q9UMD9 | |
| KDGKIRVTILARSTE | 361 | Q5NDL2 | |
| TVKGGISETRIEKRI | 806 | P11171 | |
| ISETRIEKRIVITGD | 811 | P11171 | |
| TKEGETTRLIREIDK | 366 | Q7Z3E2 | |
| VFGVKIAVVTKRERS | 1051 | P11274 | |
| RSLEKISREVKSITI | 291 | O95831 | |
| GSVRTDVRKTEKLVS | 81 | Q5NE16 | |
| GITVSREKVTEVALK | 1291 | Q02952 | |
| LKTVLAKRTGRSEVE | 1016 | Q9UIF9 | |
| TTTAEREIVRDIKEK | 201 | P60709 | |
| TTTAEREIVRDIKEK | 201 | P63261 | |
| VRGETKEVEVTKTED | 106 | Q8TF64 | |
| ITREKKDGEISRTVS | 446 | Q8N2N9 | |
| EDVKKLRTTIRSING | 211 | Q5RIA9 | |
| GRIITITKSLDREKQ | 206 | P33151 | |
| RKTTDLEIRELVTGV | 646 | Q9UQB3 | |
| EKFAETIETVLRRVK | 151 | Q96BY7 | |
| VRIADKIESGKTSVV | 421 | Q13613 | |
| SVEELRDRVKGVSAK | 771 | P15918 | |
| RIESLEEEIISKGIK | 191 | O15315 | |
| VDFKIRTIELDGKTI | 46 | P62820 | |
| KTERKEGTIIRLSDV | 221 | Q96EV2 | |
| RKDTVIKTLLVEAEG | 901 | P20742 | |
| VEKDKVTGETRVLSS | 176 | O75781 | |
| ERGLDKVITVLTRSK | 531 | Q14680 | |
| GVSSRELVKKVSDVI | 111 | O00255 | |
| VALDKARKGRTTIVI | 571 | P08183 | |
| EEVSTLRKDVTALKI | 196 | Q9UH92 | |
| REKKDGEISRTVTSE | 806 | Q5JPF3 | |
| TKEGVIIEILASRTK | 111 | P13928 | |
| IGTVDSRAESIDKKI | 21 | Q9NZZ3 | |
| EVKVTKLLDRETISG | 3391 | Q14517 | |
| TGERRLGEEIKIKIT | 86 | Q6ZTZ1 | |
| KSIERTTEDIIRSVK | 111 | Q9NP74 | |
| ADILAETGIRKTVKR | 41 | Q8IYF1 | |
| QKTTTRRIVDGKVVS | 406 | P05783 | |
| ELISSIEERKKRGET | 676 | Q9HBG6 | |
| SKKVEIIIGRTDEAV | 301 | Q9UDY8 | |
| IKTIEKTSEEERISL | 441 | Q13439 | |
| LKISEKEEVTTREVS | 76 | Q03252 | |
| KEEVTTREVSGIKAL | 81 | Q03252 | |
| EEIKEARIKRGLSVT | 1076 | Q9ULI0 | |
| DKTREIGRTRTQSKI | 166 | Q2LD37 | |
| VEIKSVRSSVEAERK | 441 | Q9ULE4 | |
| VIVEKDREKTGDTSR | 1896 | Q8IYD8 | |
| EKTTGDKRTRIQGRV | 1181 | O75197 | |
| IIESGKTLSREERKT | 231 | Q9NS86 | |
| TTRGKRKRVDVEESE | 411 | P20700 | |
| TTRDELVAKVKKRGI | 116 | Q9NXV6 | |
| EDVKKLRTTIRSING | 211 | Q9BRT8 | |
| KGGISETRIEKRIVI | 946 | O43491 | |
| RLEVGTETIIDKSKA | 126 | P54868 | |
| GVRIRETTDFKVDTK | 466 | O75369 | |
| TEISKTRGGETKREV | 2191 | Q14315 | |
| GLKDVITLRRHVETK | 156 | E9PQR5 | |
| RDSSKTRVTKTIVEE | 491 | Q2M2I5 | |
| TRVTKTIVEELVDGK | 496 | Q2M2I5 | |
| RIADKVESGKTSVVV | 401 | Q13614 | |
| ELLKVISEREKEISG | 996 | Q86UP2 | |
| EKVSKRVSAVEEVRS | 226 | Q9UJY4 | |
| GKVTTASVKERREIL | 16 | Q92616 | |
| GIVIRSVLTDKREKF | 2606 | Q9UMN6 | |
| IVTVRDVGTEKLKSE | 406 | P59047 | |
| SIVGTLEAEKERRKS | 556 | P23229 | |
| IKESIVGEIRREIVS | 1226 | P28290 | |
| EVFGRKRKKRTSIET | 276 | Q9UKI9 | |
| RTRTKLTVEELKAFV | 816 | P29375 | |
| KTDIRRISGLVTDVI | 176 | Q70UQ0 | |
| VKSKREKREVIVEES | 2976 | Q9UPN3 | |
| KRTSIEVSVKGVLET | 281 | P49335 | |
| RILEDKGTSTELVKE | 336 | Q9ULG6 | |
| TTKIVGEEVVRRKSS | 31 | Q8N9C0 | |
| VDRKITIFEVLESKG | 161 | O95393 | |
| TKEGVIIEILASRTK | 111 | Q5VT79 | |
| LSKIKGVEEEVLTRF | 226 | Q96M89 | |
| VTKGTVEEEIIERAK | 916 | O14647 | |
| KGETKTAERDVVVET | 756 | Q6ZTQ4 | |
| RVELTEESEKVSVVK | 446 | Q5SYB0 | |
| IERFREGKEKVLVTT | 376 | Q9UMR2 | |
| SRGSTEAKITEVKVE | 241 | Q9H410 | |
| EDVKKLRTTIRSING | 211 | Q5JTY5 | |
| VKRTGVSLEKLEVRE | 476 | Q6IQ26 | |
| VISDSGEKRVTITEK | 2951 | Q03164 | |
| RRIAEKGSTIETEQK | 456 | Q8N8S7 | |
| VTELTREGETIIELK | 116 | Q08722 | |
| TGEVVALKKIRLDTE | 26 | P24941 | |
| SERQKEGIKLTIRIS | 726 | Q96T23 | |
| RVRTVTVTLGDEKGK | 1461 | Q92736 | |
| GLKDVITLRRHVETK | 156 | E9PJ23 | |
| VTKEGIREETVSLRK | 226 | P20618 | |
| DGTTRRTETTVKKVV | 131 | O60716 | |
| VKGGISETRIEKRIV | 1026 | Q9Y2J2 | |
| TQIRTITEEIRDGKV | 441 | O76013 | |
| ATSKEVARLETLVRK | 911 | Q14980 | |
| RKTRETVSIEVKEVV | 306 | P51608 | |
| TVSGLREEERKEKGV | 46 | C9JL84 | |
| RRVKGKEEVTTLVTL | 2661 | O75445 | |
| VRGLKEKIVRSFEVS | 336 | Q9Y5J1 | |
| SEVKLEVETVIKTGR | 1486 | P46939 | |
| SGIVTEKVKEIRDRI | 411 | Q9UQF0 | |
| SRLDIRVGKIITVEK | 366 | P54577 | |
| ELKEGVIKIRSVASR | 471 | P49590 | |
| ELRVSTSGQKEERKV | 261 | Q3ZLR7 | |
| RKIKEKEETISSLER | 51 | A8MYB1 | |
| LRRGDVVKVLSKTTE | 86 | A4FU49 | |
| IVDKSSEKLVRGRTR | 1521 | Q5UIP0 | |
| LIRERSEKSVEITKQ | 366 | Q96T51 | |
| KREVVTAKDGRTEVA | 146 | Q9UIL4 | |
| TKLVGRVDKLEEEVS | 171 | Q68BL8 | |
| TVRRTKKLKVEEETS | 126 | Q8N5C6 | |
| SVRSISVEDKTDVRK | 846 | Q8WXE9 | |
| DKVVIVERKDGTRIV | 1436 | Q6Q759 | |
| ELRVSTSGQKEERKV | 261 | P0C7V6 | |
| TETTEVRKTKIRNGI | 936 | A0AVT1 | |
| VRIKTIKTSSGEIKR | 361 | Q9HCE3 | |
| IKTSSGEIKRTVTRV | 366 | Q9HCE3 | |
| EEAVAILKRTKGTVT | 2051 | O75970 | |
| LVSTRKGLIEVKTDE | 206 | Q9BWD1 | |
| REGILKTAKVLVEDT | 2016 | Q9Y490 | |
| KRTIRTLEDKVAEIE | 331 | Q9Y4K3 | |
| ETTSTRKIKEEEKRV | 256 | Q14258 | |
| IETRIDTAGLTEKEK | 191 | Q07617 | |
| TLKRTRKFVVDGVEV | 526 | O94804 | |
| TKERSELSKEVVTLE | 296 | Q8WXW3 | |
| SGKERRTTSKEISVI | 786 | Q5T1R4 | |
| DFRRTVKEVISVVKV | 241 | Q92994 | |
| EERVETTVTSLKTKV | 151 | Q16890 | |
| KTVKAVEDEATRGTR | 2131 | Q9Y4G6 | |
| TTTKRKEEERGAAII | 1726 | Q9UI33 | |
| VDSLGKRSDVISKVE | 531 | Q86XD8 | |
| KRSDVISKVEARDIT | 536 | Q86XD8 | |
| TGRKRTIKDLQEEVS | 531 | O94874 | |
| VIERVKGTKVKSIRT | 666 | Q9BVV6 | |
| SDKSVKIEEREGITV | 116 | Q9NRV9 |